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ABSTRACT
Type 2 diabetes is a common chronic metabolic disease affecting 23.6 million people
(7.8%) in the U.S. and is the 6th leading cause of death among adults (CDC, 2007). MexicanAmericans, the largest group within the Hispanic U.S population, have double the rate of type 2
diabetes. Long-term glucose control (HbA1C) is essential to lessen the risk of diabetes
complications; self-care demands for diabetes management may be overwhelming and creates
stress that predisposes individuals to depression and affects long-term glucose control (Anderson
et al., 2000; Black, 1999; Black, Markides, & Ray, 2003). The purpose of this study was to
evaluate the presence of depression symptoms in Mexican-American adults with type 2 diabetes
and its association with glucose control and identify factors that influence its association with
perceived stress, and physical health. Participants (N=141) with self-report of type 2 diabetes for
more than one year were recruited from private primary care clinics in El Paso, Texas. This was
a quantitative, cross-sectional study that utilized parametric and non-parametric statistical
analyses according to research questions addressed. Five questionnaires/instruments were
completed by participants and a blood sample for HbA1C was obtained. No relationship was
identified between HbA1C and depression symptoms; participants using insulin had a higher
level of HbA1C than those with oral medications. Depression symptoms (BDI-II) score was
related to sex, perceived stress, physical health, and medical history reported by participants. The
perceived stress was related to age, education, and acculturation. Physical function was related to
age and income and affected by the combination of BDI-II score and HbA1C results, and
independently by perceived stress. The implications of this study are that the high prevalence of
depression symptoms and its association with several study variables bring attention to the need
for evaluating the psychological state of individuals with type 2 diabetes. Additionally, the
percentage of participants outside the recommended HbA1C levels indicates a predisposition to
diabetes complications. The treatment approach needs to include evaluation and management of
depression on a regular basis for timely intervention. An interdisciplinary health care team
vii

approach for provision of holistic care of individuals with type 2 diabetes may be helpful in
guarding against potential diabetes complications.
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CHAPTER 1
INTRODUCTION
Type 2 diabetes is a common chronic metabolic disease affecting 23.6 million people
(7.8%) in the U.S. and is the 6th leading cause of death among adults (CDC, 2007) and it has
reached epidemic proportions in the world (WHO, 2008). Mexican-Americans, the largest
ethnic group within the Hispanic U.S. population, have a rate of type 2 diabetes nearly twice than
Euro-Americans. Along the U.S.-Mexico border the rate of diabetes has been reported as high as
16% (PAHO; Pan-American Health Organization, 2005). Maintaining near normal glucose level
in individuals with diabetes is the key factor in minimizing potential complications of this
metabolic disease. Long-term glucose control is the gold standard measure to define level of
glucose control and is monitored by primary care providers on a regular basis as part of diabetes
management. The largest portion for type 2 diabetes management falls on the shoulders of
individuals affected by this disease who have to make life-style adjustments in the most basic
functions such as eating, physical activity, and strict adherence to medications which may
interfere in their daily lives. The self-care demands for diabetes management may be
overwhelming and creates a greater level than stress; these factors predispose individuals with
type 2 diabetes to depression and affects long-term glucose control (Anderson et al., 2000;
Black, 1999; Black, Markides, & Ray, 2003).
In order to gain greater understanding of the factors that affect individuals with type 2
diabetes, a research study was carried out. This research focused on Mexican-American adults
with type 2 diabetes living in El Paso, Texas.
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Specific Study Aim
The purpose of this study was to evaluate the presence of depression symptoms and its
association with glucose control in Mexican American individuals with type 2 diabetes and
determine factors that influence its association with perceived stress, and physical health of
affected individuals.
The proposed study will assist in understanding factors that may predispose Mexican
American individuals with type 2 diabetes to depression symptoms and evaluate the impact that
these factors may have in glucose control. Knowledge gained will increase clinician’s awareness
of risk factors predisposing individuals to depression symptoms and be able to screen
appropriately and timely to create positive outcomes in the management of both conditions and
improve overall patient’s health and quality of life.
Research Questions
The research questions guiding this study are:
1) What are the demographic characteristics of individuals with type 2 diabetes?
2) Does the method of diabetes medication treatment (oral agent vs. insulin therapy) impact
Perceived Stress Score?
3) Is there a protective effect of culture on depression symptoms after controlling for age,
education, and income?
4) What is the association between depression scores and glucose control?
5) Do depressive symptoms mediate the effect of Perceived Stress on glucose control?
6) Are depression symptoms scores associated with past history of depression, reported
additional illnesses, and number of years with type 2 diabetes?
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7) What is the relationship between depression symptoms, glucose control, and physical
function?
Background and Significance
A. Diabetes
Type 2 diabetes is a serious public health problem affecting people throughout the world
and accounts for 90%-95% of the total cases of diabetes world wide (WHO 2008; CDC, 2007).
It is a chronic metabolic disease characterized by hyperglycemia caused by a defect in insulin
secretion, insulin action, or a mixture of both (Powers, 2008; Dunphy, Winland-Brown, Porter,
Thomas, 2007). Insulin is necessary for the metabolism of carbohydrates and lipids and is
especially important in the conversion of glucose to glycogen, which lowers the blood glucose
level. There are more than 180 million adults in the world affected by diabetes (WHO, 2008).
The estimated cost associated with diabetes in the U.S. exceeds $174 billion (CDC) with $116
billion spent in direct medical cost and $58 billion spent in indirect medical cost such as work
loss, disability, and early death. People with diabetes spend more than twice the amount of
money in medical costs than those without diabetes (CDC, 2007).
The long term effects of diabetes include damage to the eyes, kidneys, nerves, heart and
blood vessels (CDC, 2007). The burden of type 2 diabetes includes a greater mortality rate
associated with renal failure (10-20%) and cardiovascular disease (50%), particularly heart
disease and stroke (WHO, 2008). It is estimated that without significant action, deaths related to
diabetes will double in the next decade (WHO, 2008).
Glucose control is fundamental in the management of diabetes and has strong predictive
value for diabetes complications (UKPDS, 1998; ADA, 2010; CDC, 2007).

Glycosylated

hemoglobin (HbA1C) is a blood test used to measure average long-term blood sugar level and is
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the recommended test for determining glucose levels approximately every three months. The
target HbA1C to prevent diabetes complications is ≤7% (ADA, 2010) and is highly dependent on
the person’s ability to adhere to the indicated treatment on a daily basis. Individuals with
diabetes need to make life-style modifications in order to maintain glycemic control. Some of
the requirements are careful adherence to dietary restrictions, exercise on a regular basis, glucose
monitoring by finger stick, and often times daily intake of prescribed medications. Prescribed
medications may consist of one or more oral agents or insulin injections which may be
administered daily or more frequently depending on type of insulin used. Meticulous feet care
for observation and prevention of ulcerations is required for individuals with diabetes. Persons
with diabetes require adherence to medical visits at least four times a year and may include
additional visits to medical specialty services such as ophthalmologist or podiatrist (ADA, 2010).
Diabetes is considered one of the most demanding chronic medical illnesses because a large
portion of the disease management is carried out by the affected individual.
B. Diabetes in Mexican-Americans
Hispanics, which comprise approximately 15% of the total U.S. population is the fastest
growing minority group in the U.S. and report a 10.4% incidence of diabetes among adults 20
years and older (CDC, 2007).

Among the Hispanic population Mexican Americans (MA)

comprise the largest ethnic minority group and the incidence of type 2 diabetes doubles as
compared to the rest of the population. The prevalence of type 2 diabetes in MA adults is 11.9%
(CDC, 2007). Mexican-Americans also report higher rate of complications which include renal
disease, limb amputation and blindness; the death rate is also higher than in other Hispanic ethnic
groups (Smith & Barnett, 2005).
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The presence of type 2 diabetes is felt greatly along the U.S.-Mexico border region where
nearly 1.2 million residents (15.7%) are affected by this condition and is the third leading cause
of death for those living in the U.S. side of the border (PAHO, 2005). The U.S. side of the border
area reports a 16.1% prevalence of diabetes (PAHO, 2005). In El Paso, Texas, 13.7% of the
population reported having diabetes (Martinez & Bader, 2007) whereas a colonia in El Paso
County reported an incident rate of 11% (Anders et al., 2008).
Individuals with diabetes and depression sustain higher health care expenses than
individuals with diabetes without depression (Katon, 2005). Approximately $92 million are
spent in added cost of treatment associated with diabetes and depression (Egede, Zheng, &
Simpson, 2002).
C. Depression
Depression is the leading cause of disability in the U.S. and approximately 7.5% (63
million) of the adult population report having at least one episode of depression within the past
year (SAMSHA; Substance Abuse and Mental Health Services Administration, 2008) but the
life-time prevalence rate increases to 15.2%; recurrent events of depression are common and
increase in frequency after each episode (CDC, 2007). Approximately 66% of those affected are
reported as having received treatment in the past year. Depression is more prevalent in women
than in men (NIMH; National Institute of Mental Health, 2008). The Diagnostic Statistical
Manual of Mental Disorders (DSM-IV) manual of mental disorders (APA; American Psychiatric
Association, 1994) describes Major Depression Disorder, also called depression, as a clinical
condition that is characterized as having one or more occurrences of a Major Depressive
Episode. Major Depressive Episode is defined as at least two weeks of depressed mood or the
loss of interest and enjoyment in most of activities and persists for most of the day, nearly every
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day. The person must also experience at least four additional symptoms from the following:
decreased energy, increased fatigability, decrease in activity, difficulty thinking, concentrating,
or making decisions, feelings of worthlessness or guilt, disrupted sleep or psychomotor activity,
change in appetite or weight, recurrent thoughts of death or suicidal ideation, plans or attempts
(APA, 1994). Depression can contribute to or worsen chronic diseases (CDC, 2007). The
presence of depression as a comorbidity has been associated with greater physical impairment,
poorer perceived health, and increased medication and health care utilization (Black, Ray, &
Markides, 1999).
D. Depression in Mexican Americans
The reported prevalence rates of depression in Mexican American population are varied
and not clear as statistics reported are mainly of the whole Hispanic ethnic group. A study by
Riolo et al. (2005) utilized data from the National Health and Nutrition Examination Survey III
carried out from 1994 to 1998 by the National Center for Health Statistics to evaluate prevalence
of depression by race and ethnicity in the U.S. The listed sampled population was 8,449 and
identifies an oversampling of African Americans and Mexican Americans to attain reliable
samples. However the publication does not list the total of the population for each of the ethnic
groups included (White, African American, and Mexican American). The depression rate of
Mexican Americans (MA) was 8% and similar to African Americans (7%); Whites had the
highest rate (10.4%). Low educational level and low income have been recognized as risks for
depression in this ethnic group (NIMH, 2008; Shmaling & Hernandez, 2005). Hispanics with
depression receive less appropriate care for mental illness than Whites (CDC, 2007). Depression
symptoms may go undetected in this population because Hispanics tend to emphasize somatic
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symptoms and often seek help from primary care providers rather than from mental health
providers (Shmaling & Hernandez, 2005).
Access to health care services, especially to mental health care services, is limited
because of the lack of health insurance (NIMH, 2008). The length of time living in the U.S. and
acculturation level has been identified as risk factors for depression; immigrant Mexicans have
less depression than U.S. born Mexican Americans (Shmaling & Hernandez, 2005). The longer
the person has been in the U.S. the greater the possibility of depression. Acculturation to main
stream America also appears to influence the presence of depression symptoms; lower
acculturation may lessen the presence of depression symptoms (Cheriboga et al., 2007). The
presence of strong social support networks and interpersonal functioning have been associated
with less depression and are believed to guard against mental health problems in general
(Hernandez et al., 2005).
E. Diabetes and Co-existent Depression
Depression in individuals with diabetes is approximately 2.5 times more likely to occur
than in those without diabetes (Anderson, Freeland, Clouse, & Lustman, 2001; Egede, Zheng, &
Simpson, 2002). The depression rate reported among participants with type 2 diabetes residing in
a colonia in the US/Mexico border was 20% (Solis, Wiebe, & Anders, 2008). The health care
expenses sustained by individuals with diabetes and depression are higher than those with
diabetes alone (Ciechanowski, Katon, Russo, 2000; Katon, 2005). Approximately $92 million
are spent in added cost of treatment associated with diabetes and depression (Egede et al., 2002).
A meta-analysis study conducted by Lustman et al. (2000) identified a relationship between
depression and uncontrolled glucose levels in patients with diabetes. Diabetes complications and
mortality for individuals with depression has been reported as being greater than in individuals
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with diabetes without depression (Egede, Nietert, Zheng, D., 2005; Katon et al., 2005). The
microvascular and macrovascular complications of diabetes are augmented by the presence of
depression in diabetes thus contributing to the increased mortality rate in this population (Black,
Markides, & Ray, 2003). In spite of the known devastating effect of depression on diabetes, only
31% of patients with diabetes and depression received adequate antidepressant treatment and
only 6% received 4-5 sessions of psychotherapy in a 12 month period (Katon, 2008).
Stress may affect glycemic control in two ways; through the psychological mechanisms,
and through the effects of treatment adherence. The negative effect of depression is that it may
interfere with the person’s ability to carry out the tasks required to control glucose and ultimately
may affect glucose control (Skinner, 2004). Individuals with concomitant diabetes and
depression have reported greater difficulty with adherence to many aspects of self-care activities
(Katon et al., 2005; Skinner, 2004). The psychological demands associated with diabetes selfcare regimen and the incidence of complications associated with poor glucose control resulting
in functional impairment may influence the presence of depression and its severity (Katon, 2008;
Tafet & Smolovich, 2004).
The increased vulnerability to depression in individuals with type 2 diabetes is not yet
clearly understood (NIMH, 2005). However, depression involves physiological changes of the
neuroendocrine system. The underlying cause of depression is thought to be related to changes
in the neurotransmitters in the brain such as Serotonin (5-HT), dopamine (DA), and
norepinephrine (NE) which are monoamine neurotransmitters which affect mood and behavior.
It is believed that during psychological stress counter regulatory hormones such as
catecholamine a neurotransmitter, glucocorticoids, growth hormones, and glucagons are
activated (Grisel, Rasmussen, Sperry, 2006). The activation of the counter regulatory hormones
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interferes in the action of insulin which is not able to lower glucose but instead elevates blood
glucose. The increase in glucose level creates a greater challenge in maintaining metabolic
control. Poor glycemic control and functional impairment due to increasing diabetes
complications may cause or worsen depression and lessen the response to antidepressant
treatment (Lustman & Clouse, 2005).
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CHAPTER 2
LITERATURE REVIEW
Overview
Since the late 1990s many studies have been conducted in evaluating the presence of
depression in individuals with diabetes and trying to understand the factors contributing to this
dyad. The cause for this occurrence has not been clearly identified. However, the major factors
identified in the association and/or affected by the coexistence of depression in diabetes are: (1)
burden of disease with an increase in morbidity and mortality (Black, 1999; Black, Ray, &
Markides, 1999; Black, Markides, & Ray, 2003; Anderson et al., 2001), (2) contributor of
glucose control (Anderson et al., 2001; Fisher et al., 2001; Gross et al., 2005; Lee et al., 2009;
Mier, Medina, & Ory, 2008; Pineda-Olvera et al., 2007); (3) adherence to diabetes
demands/treatment which may increase glucose level and stress (Rivera, 2003; Sacco et al.,
2007; Spencer et al., 2006), and (4) effect on health-related quality of life such as quality of life
exhibited by reported decline in physical, social, role functioning, and perceived health status
(Black & Markides, 2003; Ciechanowski, 2000; Fisher et al., 2001; Gross et al., 2005;
Kaholokula et al., 2006; Lee et al., 2009).
B. Quality of Life
The burden of personal diabetes management creates significant physical and emotional
stress which diminishes quality of life and is thought to be a major contributor to presence of
depression (Anderson et al., 2000; Black, 1999; Black, Markides, & Ray, 2003; Golden, Lazo,
Carnethon, 2008; Katon, 2008). The stress may not always be physiologically related but may be
due to the disease burden on patients with limited income and education. In a study by Spencer et
al. (2006), diabetes-specific emotional distress was identified to be correlated with education and
10

income in the Hispanic group. In recent study individuals with type 2 diabetes with and without
depressions were compared, results indicated that the physical and mental health summary score
of individuals with depression was worse than those without depression (Lee et al., 2009).
C. Mexican-Americans with Diabetes and Depression
The coexistence of type 2 diabetes and depression among Mexican Americans has been
reported mainly in retrospective studies (Anderson et al., 2001; Black, 2000; Black et al., 2003).
Most of the information gained on the presence of depression and diabetes in Mexican
Americans has derived from the Hispanic Established Populations for the Epidemiological
Studies of the Elderly (HEPESE) limiting the number of studies available in this population. The
HEPESE study included 3,050 participants 65 years of age and older and most were Mexican
American.

It is the first largest study of Hispanic community residents from the five

southwestern United States (Texas, California, Arizona, New Mexico, and Colorado)
approximately 85% of the participants were identified as Mexican American (MA) (Black et al.,
2003). The rate of depression in individuals who self-reported having diabetes was 31% (n=636)
and the non-diabetic group was 24.1% (n=2,196) (Black, 1999). The EPESE surveys were
conducted in various series; the first was from 1993 to 1994, the second from 1995 to 1996, the
third from 1998-1999, and the last wave from 2000-2001 (Black, 1999; Black, Ray, & Markides,
1999; Black et al., 2003). The EPESE study included multiple measures to gain comprehensive
knowledge of the health state of Hispanic elders. The limitations of these studies is that they
have been conducted in an older population which has a greater incidence of type 2 diabetes than
in a younger population (CDC, 2007), and the validity of self-report of diabetes without
evaluation of glucose level comes to question.

11

The metabolic control, measured by the HbA1C, associated with diabetes and depression
was evaluated by Pineda-Olvera et al. (2007) in a group of Latina women (N=96) between the
ages of 18-65 years who received care in community clinics in the West Dallas, Texas area.
Metabolic control was examined based on the HbA1C recorded in the medical record six months
before the interview. Only 84% (n=81) had a HbA1C recorded. The mean educational level of
participants was 6th grade (SD= 3.9) and the mean income was $12,957 (SD= $7,385). The rate
of depression using the Center of Epidemiologic Studies Depression Scale (CES-D) in this group
was 32.3% (n=31). The average HbA1C in the depressed group was 9.09% (SD= 2.15%)
whereas the non-depressed group was 7.94% (SD=2.30). The correlates identified with poor
metabolic control were: number of years with diabetes, demographic and disease related
variables. Social support was also measured in the study and those with increased support had
better glucose control. This study is one of the few that evaluated the effect of depression in
glucose control in a Latino group; approximately 68% of the participants were MexicanAmerican. The limitation from this study is that it was conducted in women, who have a higher
incidence of depression (NIMH; National Institute of Mental Health, 2008) and the HbA1C was
completed six months prior to data collection with only 80% completion.
One of the recent studies of MA is a cross-sectional study from a survey conducted from
2004-2005 (Mier et al., 2007) which evaluated the personal and social factors that may influence
on the prevalence of depression symptoms in Hispanic adults 18 and older with self-report
diagnosis of type 2 diabetes. The research was carried out in two population groups in the Lower
Rio Grande Valley in South Texas: one in Southern Texas, US (n=172), and in Tamaulipas,
(Northern) Mexico (n=200). Participants were asked to identify frequency of glucose monitoring
and whether this was a painful procedure in order to elicit information on the barriers
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encountered with diabetes management. The findings identified that the burden of diabetes
symptoms was the greatest predictor of clinical depression symptoms.

The rate of depression

measured with the Center for Epidemiological Studies Depression Scale (CES-D) was similar in
both groups (39% and 40.5%). The population in the Southern Texas area is much like that in El
Paso County.
Mier et al. (2008), in collaboration with additional co-authors, published further
components of the same research study and focused on evaluating current state of recommended
national guidelines for co-existing conditions with type 2 diabetes. The study addressed the
relationship between depression symptoms, measured by the CES-D, and self-report health
factors of co-existing conditions such as high cholesterol, hypertension, and heart disease. The
study also evaluated the participants’ experiences in diabetes management. The correlation
between depression symptoms and the recommended HbA1C was evaluated. Reported glucose
control was an HbA1C level completed within a year and recorded in the medical record. A
positive correlation between depression symptoms and HbA1C was reported in this study. This
study is valuable in identifying the prevalence of depression in Mexican Americans but no
identification of its effect on glucose level.
Literature review support the presence of depression in individuals with diabetes and
worsening condition of diabetes control is acknowledged. However, only two studies (PinedaOlvera et al., 2007; Fisher et al., 2004) evaluated HbA1C. The data for glucose level was
incomplete in the Pineda- Olvera et al. (2007) study with only 84% of the participants having an
HbA1C recorded in the medical record. The lack of consistency and uniformity in glucose
testing is not addressed in the Fisher et al. (2004) study. Additionally, most of the information
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ublished in the coexistence of diabetes and depression is the result of the Hispanic-EPESE study
conducted in elderly.
The proposed study will provide the opportunity to evaluate the presence of depressive
symptoms and their relation with glucose levels by obtaining a HbA1C at the time of the
interview which has not been done previously in MAs.
Conceptual Framework
The framework is based on the premises that glucose control in individuals with type 2
diabetes is influenced by the person’s psychological state. Persons with type 2 diabetes require
adherence to the following: specific dietary intake, exercise on a regular basis, daily intake of
medications, regular visits to health care providers, and meticulous foot care. Carrying out these
demands require personal motivation, adequate finances, access to health care and ongoing
social/familial support. The demands created by this condition place the individual at risk for
chronic psychological stress. Lazarus (1966, p.2), who is credited for expanding the concept of
stress, defines stress as a “universal human phenomena that results in intense and distressing
experience and appears of tremendous influence in behavior”. According to Lazarus, the person
determines the level of stress caused by the condition based on the personal perception of the
situation or events. The definition of stress was broadened further by Lazarus & Folkman (1984)
to try to identify individual differences in the perception of the stressor and in understanding the
response to stress. Therefore, it is now considered that the person’s ability to adapt to the stressor
is determined based on the following: the life event affecting the person (stressor), the person’s
coping ability, the person’s characteristics, and by the person’s environment (Lazarus &
Folkman, 1984). Persistent stress creates a psychologically negative stimulus that initiates a
physiological response to stress. Depression symptoms are a type of negative effect which
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occurs when the situation is appraised by the individual as hopeless or overbearing.

A

relationship between stress/diabetes and metabolic effect has been described by Golden (2007).
A three tier framework (Figure 1) is drawn to illustrate the factors that predispose MA
individuals with type 2 diabetes to depression symptoms and ultimately exerts an effect on
glucose control. The first tier lists the personal characteristics of the individual affected, type of
diabetes treatment, and components of the medical history as basis for creating chronic stress and
increasing possibility of depression symptoms. Mexican Americans are at high risk for limiting
self-care and affecting diabetes management because of their limited health care services due to
lack of health insurance, low level of education, and lower income level as compared to other
ethnic groups. Acculturation plays a role in the propensity of MA to experience depression
symptoms; lower acculturation to American mainstream culture, means less propensity to
depression symptoms. Individuals with type 2 diabetes who require daily Insulin injections have
been reported as having more stress and more risk for depression symptoms than those who only
take oral medications. The addition of chronic illnesses and the longer the person had had
diabetes the higher the possibility of developing depression symptoms. Additionally, recurrence
of depression over the life span increases with each experienced episode of depression; thus
individuals with diabetes who have past history of depression will be more likely to report
depression symptoms.
The second tier of the framework identifies perceived stress (PSS) as being a possible
consequence to type of treatment and demographic characteristics thus predisposing individuals
to occurrence of depression symptoms and affecting glucose control. The presence of depression
symptoms (BDI-II) is seen as a mediator between the effects of perceived stress on glucose
control (HbA1C).
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The third tier of the framework indicates how the presence of depression symptoms may
interfere with the person’s physical activity. The lack of physical energy and possibly decreased
motivation which may be seen as depression symptoms interfere in diabetes self-management
and glucose control. Physical function is seen as a bi-directional effect on depression symptoms
(BDI-II) and on glucose control (HbA1C).

Treatment:

Demographics:

Medical History:

Oral vs. Insulin

Age, Gender,
Education, &
Household Income

Time with DM
Added Illnesses
Past Depression

Acculturation

Perceived Stress
Score (PSS)*

Depression Symptoms
(BDI-II) **

Physical Function
(SF-36v2, PCS)***

Glucose Control
(HbA1C)

Figure 1: Conceptual Framework
Note: *PSS: Perceived stress scale. Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of
perceived stress. Journal of Health and Social Behavior, 24 (December), 385-396.
**BDI-II: Beck Depression Inventory. Beck, A.T., Steer, R. A., & Brown, G.K. (1996). BDI-II manual (2nd ed.).
The Psychological Corporation. San Antonio, TX: Harcourt Bruce & Co. ***Physical Component Summary (PCS).
Ware, J.E. & Kosinski, M.A. (2001): SF36 Physical and mental health summary scales: a manual for users version 1
(2nd ed.). Lincoln, RI: Quality Metric Inc.
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CHAPTER 3
DESIGN AND METHODS
This was a cross-sectional descriptive study for the purpose of evaluating the presence of
depression symptoms and their association with glycemic control (HbA1C), perceived stress, and
physical function in Mexican- American (MA) adults with type 2 diabetes. The knowledge
gained of the association between diabetes and depression symptoms and the factors influencing
this dyad will assist health care practitioners to better understand this condition and design
treatments that address the psychological and the metabolic needs of affected individuals to
improve overall health outcomes.
Research Setting
El Paso, Texas is a city in El Paso County, and is located along the US-Mexico border
whose residents are predominantly of Mexican American origin. Approximately 78% of the
Hispanic residents were born in Mexico or are of Mexican descent (US census bureau, 2005).
The city of El Paso is the largest border city along the U.S./Mexico and the latest statistics reveal
an 8.1% prevalence of diabetes among Hispanics as compared to 5.5% of non-Hispanic (Texas
Department of State Health Services, 2008). The prevalence of diabetes in the area has been
reported as high as 13-15% (Anders et al., 2008; Martinez & Bader, 2007). Previously reported
rate of depression among individuals with diabetes residing in a colonia in El Paso County was
20% (Solis, Wiebe, & Anders, 2008). Participants were recruited from several private family
clinics on the East side of El Paso, TX South of I-10 Paso where approximately 35% of the city’s
population resides (US Census Bureau, 2005). The clinics were located within a 2-mile radius
from each other and share a similar patient population.
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The participating clinics were Candelaria Medical Center, Tarango Family Clinic, and
Valley Medical Clinic. Persons who receive health care services in private practice settings tend
to have coverage for services. Provision of coverage may be from private insurances, state, and/
or federal programs. The selected sites provide primary care services with similarity of
population served. Additionally these health clinics serve a similar demographic population. A
written agreement from each participating site will be obtained prior to recruitment of
participants to create a cooperative environment that would lead to satisfactory relationship
between PI and Health Care providers (Appendix A).
Sample Population
This was a convenience sample of adult population. Participants were recruited from the
previously listed clinics while waiting to be seen by their health care providers. he inclusion
criteria for this study were: 1) males and females 18 years old and older who self-report being
diagnosed with type 2 diabetes by a health care provider; 2) self-report type 2 diabetes for one
year or longer; 3) ethnically identified self as Mexican (born in Mexico), Mexican- American, or
of Mexican descent whose parents or grandparents were born in Mexico; 4) under medical care
for diabetes treatment in the U.S. 5) able to read and write English, Spanish or both in order to
complete forms and questionnaires 6) willingness to participate in this study. Criterion Four was
established for Primary Investigator to be able to inform health care provider of HbA1C
results.The exclusion criteria were based on self-report of the following: 1) physical and or
mental conditions that interfere with participation, 2) Inability to obtain venous blood sample,
and 3) End-stage Renal Disease.
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Sample Size
The prevalence of depression in Mexican American individuals with diabetes has been
reported between 20-40% (Anders et al., 2008, Black, Markides, & Ray, 2003). The effect size,
used for sample analysis, was based on determining the association between diabetes and a
presence of depression symptoms. A multiple regression statistical analysis was conducted. An
F test calculation was conducted taking into consideration 12 predictors, Effect size f² = .15,
α= 0.05, and Power (1-β err prob)= 0.80. This yields an N= 127 (Faul, Erdfelder, Land, &
Buchner, 2007). Because of the possibility of participant attrition, such as not completing all
study questionnaires, 13 participants (10%) have been added to the calculated sample size
leading to a grand total of N= 140 participants.
Participant Recruitment Procedure
The Primary Investigator (PI) or the Research Assistant (RA) obtained written approval
for patient recruitment from each of the selected clinical sites. A brief written screening for
recruitment of participants was conducted by the PI or RA to identify potential participants in the
following manner: every person in the waiting area was given a note where potential participants
identified themselves as willing to talk to the investigator (Appendix B). If the person agreed to
talk to the investigator for possible participation, the informed consent was read and obtained by
the PI or RA; questions posed by the participant were answered in the participant’s selected
language prior to further proceedings (Appendix C and D). Once the consent was signed,
verification of inclusion and exclusion criteria took place.
The questionnaires required for the study were presented and explained for its completion
during this session. The forms and questionnaires that were completed included: 1) Information
of to the Health Care Provider notifying of patient’s participation in the study, 2) Demographic
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questionnaire to gain information on participant, 3) BDI-II to measure depressive symptoms, 4)
SF-36v2 Physical Cumulative Score for evaluating physical function, 5) Perceived Stress Scale
to measure level of stress, and 6) Acculturation scale to determine level of acculturation to U.S.
culture.
The PI and or the R A were available on site at all times to clarify or assist in the
completion of the materials. All participants completed the questionnaires in a private area in the
clinic.
A venous blood test, in a non-fasting state, was drawn for measuring the HbA1C during
the same session. A certified phlebotomist was available on site to obtain the sample and
forward it to a National Certified Laboratory in El Paso, TX that was contracted for this study.
Results were available to the PI within 10 working days. Water and low carbohydrate snacks
were available for participants during the data collection period to maintain energy level during
the completion of questionnaires.
A note was given to each participant to take to their health provider notifying them of
patient’s participation in the study (Appendix E). Additionally, participants provided PI with
addressed envelope listing to notify of their HbA1C results if ≥8%. If the HbA1C was ≥8% but
≤9.0%, a report of the result was provided to the patient by the PI, via certified mail, to take to
their health care provider in their next scheduled appointment. If HbA1C ≥9.0%, a glucose
equivalent to (240 mg/dl) the PI provided a note to the patient, via mail, to take to their health
provider within 30 days listing the results of the HbA1C (Appendix F). The participants received
a gift card for $15.00 redeemable at a local store as a token of appreciation for their valued time
and information.
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The RA, who is a graduate student in a Master’s program with experience in data
collection, was trained by the PI prior to initiation of the study to assist in the recruitment and
administration of questionnaires. The RA and PI are fluent in Spanish and fully aware of
Mexican-American culture and were able to interact with participants and explain or clarify
information presented. Retraining took place after the first week of the research study based on
the need of the RA and PI to clarify the procedure for participating clinic staff. The RA was also
responsible for inputting the data in an Excel spread sheet at the completion of data collection
process.
Instruments
1. Measure of Depression Symptoms
The presence of depression symptoms was evaluated using the Beck Depression
Inventory-Second Edition (BDI-II; Beck, Steer, & Brown, 1996). The term “depression” in this
study referred to the self-report of depressive symptoms indentified in the BDI-II. The BDI-II
was developed to assess the presence of symptoms that are aligned with the criteria for
diagnosing depressive disorders described in the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV; American Psychiatric Association, 1994). The BDI-II alone does not serve
as a diagnostic measure for depression.
The original instrument was the BDI published in 1961 based on described symptoms
reported by psychiatric patients with depression and not often reported by psychiatric patients
who were not depressed (Beck et al., 1996). The format of the BDI-II test is for the participants
to select and circle the number beside one of the four phrases listed that best describes their state
in the past two weeks including the day the questionnaire is answered. The instrument consists
of 21-items/statements that are self-reported and takes approximately 10 minutes to complete,
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and require a fifth– sixth grade reading level to adequately understand the questions. The score
ranges from 0-63 to determine possible degree of depression symptoms.

The instrument

developers established four groups of scores and classified as the following: “minimal 0-13, mild
14-19, moderate 20-28, and severe 29-63” (Beck et al., 1996, p.11). Scores provide an estimate
of the overall symptom severity of depression. High scores indicate greater depressive
symptoms. It is suggested that if the question regarding suicide and hopelessness are rated with
high scores then the participant should be evaluated for potential suicide.
The psychometric properties of the BDI-II English version (Beck et al., 1996) report an
internal consistency α= .92 when evaluated in 500 outpatients and a coefficient α= .93 for 120
college students. Test-retest evaluation on the stability of the BDI-II was based on its
administration to 26 outpatients on two occasions, during a first visit and repeated one week
later. The test-retest correlation was 0.92 (p<.001). The validity of the BDI-II was reported by
same authors, who describe the content validity. The BDI-II was developed to examine for
presence of depression symptoms based on the criteria for depression listed in the DSM-IV.
Convergent validity was carried out by administering the BDI-I and the BDI-II for the first
session and another instrument was administered between the two versions. The correlation
identified between BDI-I and BDI-II was .93 (p<.001).
The BDI-II is available in English and Spanish. The reliability and factor structure of a
translated Spanish BDI-II version were evaluated by Wiebe, Penley, & Nwosu, (2003), using a
group of medical patients with end-stage renal disease (ESRD) receiving hemodialysis (n=122)
in a predominately Hispanic population. The BDI-II was translated into Spanish by several
psychologists from the “U.S., Mexico, Central and South America, Cuba, and Puerto Rico”
(Wiebe, Penley, & Nwosu, 2003, p. 570). The internal consistency of the Spanish version is
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reported as α=.92. The item-total correlations ranged from .33, in the suicidal thought or wishes
item, to .72 in the item listing worthlessness. The factor analysis carried out using confirmatory
factor analysis of same type population and led to acceptable fit of the model that identified
general depression factor. The construct validity of the translated Spanish BDI-II was also
established by identifying a single construct of depression.
A comparison of the psychometric properties of the BDI-II in English and Spanish was
carried out by Wiebe & Penley (2005) in a sample of undergraduate college students (N=895).
Participants were primarily Hispanic with most being bilingual. The results demonstrated a
similarity of both languages. The reliability measures in the English version was α=.89 and in
the Spanish version was α=.91. Test-retest reliability was carried out by administering the
questionnaire one week apart either in the same language each time or in a different language
during each session and the results were acceptable. The ICC for the English version was .71
(p<.001) and Spanish version was .86 (p<.001). The scores of those who completed the
questionnaires in both language versions one week apart, the ICC was .76 (p<.001). The
confirmatory factor analysis was used to evaluate the factor validity of the BDI-II in English and
Spanish. This evaluation showed that the English version factor structure demonstrated a good fit
with the data from the Spanish version.
2. Serum Glycated Hemoglobin Measure (HbA1C)
Glycated hemoglobin reflects a proportion of glucose level in the blood which occurs
when glucose enters the red blood cell. Glycated hemoglobin is a substance in the red blood
cells formed when blood glucose attaches to the hemoglobin. It is used to measure blood glucose
control over several months and provides an estimate of how well diabetes has been controlled
over the last 2 or 3 months. It is the goal standard of care for determining potential risk for
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developing problems, such as retinopathy, renal disease, cardiovascular disease, peripheral
neuropathy or stroke. Potential complications are especially true if HbA1C remains high for a
long period of time (ADA, 2010). The goal for HbA1C in adults is ≤7%; normal HbA1C levels
for individuals without diabetes is <6.5%; glucose control is fundamental to the management of
diabetes (ADA, 2010). The HbA1C test accuracy may be affected by conditions that affect red
blood cell turnover such as hemolysis (red blood cell destruction) and significant blood loss
(Dunphey et al., 2007).
Serum blood test for HbA1C was obtained on the same day and in the same clinic site
either before or immediately after completing the questionnaires depending on time available in
clinic. The blood sample was obtained by venous puncture drawn by a certified phlebotomist and
sent to a designated local laboratory with coded identification number.
3. Physical Health Scale an indicator of Quality of Life
The Short Form Health-Related Quality-of-Life Questionnaire (SF-36v2) was designed as
a tool to evaluate the physical and mental components of health to draw deductions of an
individual’s quality of life (Ware & Kosinski, 2001). This instrument measures the following
eight dimensions of health: physical functioning, role limitations due to physical health, bodily
pain, general health, vitality, social functioning, role limitations due to emotional health, and
mental health (Ware & Kosinski, 2001).

Aside from the dimension scores, a Physical

Component Summary (PCS) and the Mental Component Summary (MCS) can be derived from
the scales. A Likert-type scale score format is used for scoring each item from 1-5. The higher
scores describe better health. Each item is scored and evaluated to produce a standardized score
ranging from 0-100. Norm-based scoring and interpretation is determined by standardization of
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mean scores (50) and standard deviations (10) to the general U.S. population It is a self–
administered 36-item questionnaire which is completed in approximately 7 to 10 minutes.
The psychometric properties of the SF36V2 were documented, including internal
consistency reliability, which ranged from α=.90 to α=.94 for the PCS scale and α=.85 to α=.90
for the MCS scale. The test-retest reliability for a two-week interval between administrations, in
the U.S., identified the following correlation scores: 0.87 for the PCS and 0.74 for the MCS
(N=540) (Ware & Kosinski, 2001). Validation methods used in studies of the SF-36v2 follow
recommended guidelines by the American Psychological Association, the American Educational
Research Association, and the National Council on Measurement in Education which helped
design interpretative criterion for the eight scales (Ware & Kosinski, 2001, p.45). The eight
scales include health concepts that are highly representative of a person’s health status.
Studies have yielded content, concurrent, criterion, and predictive validity evidence in
various applications (Ware & Kosinski, 2001).

Reliability and validity of the Spanish version

for this instrument was documented in Mexican-American elderly group (N=150) an internal
consistency of α=.80 was demonstrated with content validity established with the use of a
generic health survey used in a similar population (Bennett & Riegel, 2003). Construct validity
of the PCS and MCS scale was evaluated with the medical outcome study, measures specific
symptoms of physical and mental state, and a strong correlation was identified (r=0.70) (Ware &
Kosinski, 2001).
The reliability and validity of the SF-36 was examined in a group of older Mexican
Americans (N=621) from the Hispanic Established Populations for Epidemiologic Study of the
Elderly by Peek et al. (2004). The internal consistency for the eight scales was α=.76-.96. The
construct validity was evaluated using a confirmatory factor analysis to fit a model using eight
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factors that would denote the eight SF-36 scales. The acceptable levels established for
determining evidence of construct validity for the model fit was >.90 in the comparative fit index
(CFI) and the normed fit index (NFI). Each of the items loaded at .60 or higher except for
general health item which was .59. However, most of the items loaded at ≥.80, supporting the
construct validity of the instrument.
4. Demographic Questionnaire
A questionnaire was designed for this study to gain information that would assist in
obtaining biographical and health history of the participants. The contents included personal
descriptive data such as age, gender, years of education, and income. Personal identification
information that may breach confidentiality of participants was not be included. The inclusion of
address was obtained separately to be able to send results of HbA1C, if desired. Information was
obtained on medical history, current pharmacological diabetes treatment, and whether treatment
for depression was in progress. The medical history components is a list of nine illnesses
commonly identified with type 2 diabetes where the response is in a dichotomous (yes/no)
format with an option to write in additional illnesses not included in the list. The questionnaire
was available in English and Spanish and participants selected the preferred language version
(Appendix G and H).
5. Stress Appraisal
The Perceived Stress Scale (PSS) is used to measure the degree of stress perceived by
each participant (Cohen, Kamarck, & Mermelstein, 1983). It is rated on a 5-point Likert type
scale ranging from 0 (never) to 4 (very frequently). Higher scores indicate higher perceived
stress. It is a 14-item questionnaire. The PSS score results by reversing the score on the seven
positive items: 0=4, 1=3, 2=2, 3=1, 4=0, and adding across all 14 items. Items 4, 5, 6, 7, 9, 10,
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and 13 are the positively stated items. It can be administered in few minutes and can be scored
easily. The PSS is sensitive to measuring chronic stress occurring from life circumstances, stress
from expectations regarding future events, or stress from particular life events. Based on three
sample groups, two of college students and one from a community group, the internal
consistency reliability was α=.84, α=.85, and α=.86 respectively (Gonzalez-Ramírez & LanderoHernández, 2007). The evidence for concurrent and predictive validity of the PSS was gathered
using correlation between the four additional scales and the PSS. The four scales measured life
events, social anxiety, depressive symptomatology, and physical symptomatology. A positive
correlation was established between life events, physical symptoms, and social anxiety scales
and the PSS with a significance level of p< .001. A high correlation was noted between the PSS
and the depressive symptom scale but both scales predicted independently physical
symptomatology when partial correlations were calculated (Appendix I and J).
The PSS scale was translated into Spanish and used in Guanajuato, Mexico to investigate
the influence of perceived psychosocial stress in patients with diabetes mellitus type 2 (GaraySevilla et al., 2000). The PSS was further analyzed for cultural adaptation of the Spanish version
for its use in Mexican population samples (Gonzalez-Ramírez & Landero-Hernández, 2007). A
random sample of university students was used for the study and the internal consistency was
analyzed and the factor structure of the Spanish version was compared with the factor structure
of the English version. The reported internal consistency was α=.83 and confirmatory factor
analysis substantiated the factor structure (Gonzalez-Ramírez & Landero-Hernández, 2007).
6. Acculturation Measure
Acculturation has been described as a change process that takes place from continuous
exposure between two cultural groups and is presumed to adopt the behaviors and values of a
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dominant culture (Berry, 1980). The degree of acculturation was evaluated based on language
using the five-item Short Acculturation Scale for Hispanics (SASH; Marin et al., 1987). The
questionnaire is self-administered and uses a Likert-type scale with five items with responses
ranging from one to five. Score range is from 5-20 with higher score indicating higher
acculturation. The statement items included in the questionnaire were created in either English
and or Spanish and then each translated using the back-translation technique to evaluate
language. Both language versions of the acculturation scale were pretested and Spanish speakers
representing several nationalities reviewed the Spanish questionnaire to minimize wording
unique to the areas where developed (Marin et al., 1987).
The reliability for the SASH five items that evaluated the language factor was α=.90.
The validity was established by correlating the participant’s total score of the questionnaire and
on each factor with the participant’s generation, proportion of time spent living in the U.S., and
the participant’s self-evaluation of his and her level of acculturation (Marin et al., 1987, p.190).
The correlation between language and each of the criteria listed above carried out for Mexicanmericans ranged from r=.70-.84 and had statistical significance of p<.001. (Appendix K and L).
Data Management and Statistical Analysis
1. Pre-Analysis
During the pre-analysis phase, the data were coded to maintain confidentiality for all
participants. Participants were given an identification number assigned by the PI for use
throughout the study. The original documents are being kept in a secured file cabinet, on the
fourth floor of the College of Health Science; the PI is the only person able to access this
information and will be secured for five years. In order to carry out quantitative statistical
analysis, measurement for variables was established. Demographic information and summative
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score of the instruments was obtained as a continuous measure as much as possible to ease the
process of designation measure according to statistical analysis. The data were evaluated by the
PI for outliers or coding irregularities. It was also cleaned for accuracy and irregularities by the
PI after the RA inputted the information. A computer file was established to prepare for further
evaluation and analysis. The data were entered onto an Excel format computer file and the SPSS
(Statistical Package for the Social Sciences) statistical software was used for data analysis.
In the preliminary assessments for data analysis, the Expectation maximization (EM)
method for forming a missing data correlation was used (Tabachnick, & Fidell, 2007) for
inputting any randomly missing data. The EM creates a missing data correlation matrix by
assuming the shape of the distribution for the partially missing data and bases inference about the
missing values on the likelihood under that distribution. The SPSS has the capability for
performing EM. This was created using the same statistical software.
In the final assessment of data analysis it was opted not to use EM for missing data but
rather compute statistics with the actual obtained sample since few variables missing.
2. Statistical Analyses
A cross-sectional, exploratory research method study was used to evaluate the presence
of depression in Mexican American individuals with type 2 diabetes and determine its
association with glucose control, perceived stress, and physical function of participants. Table 1
lists each of the research questions, the variables included in each questions, and the statistical
analysis carried out to answer each question.
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Table 1. Research Questions and Statistical Analysis Conducted
Research Questions

Instrument

Statistical Analysis

What are the demographic
characteristics of individuals with type
2 diabetes?

Demographic Questions

Descriptive Analysis

Does the method of diabetes
medication treatment (Oral vs. Insulin)
impact PSS score?

PSS score (DV)
Method treatment: oral vs. insulin (IV)

t-test: Two tailed-test

Is there a protective effect of
acculturation in depression symptoms
after controlling for age, education,
and income?

BDI-II (DV)
Age, education & income (Contol)
Acculturation (IV)

Multiple Regression:
Hierarchical Model

What is the association between
depression symptoms score and
glucose control?

HbA1C (DV)
BDI-II (IV)

Pearson r correlation

Do depressive symptoms mediate the
effect of Perceived Stress on Glucose
control?

A1C (DV)
PSS (IV)
BDI-II (DV & IV)

Multiple Regression: Mediation

Are depression symptoms associated
with past history of depression,
reported additional illnesses, and
number of years with type2 diabetes?

BDI-II (DV)
Step 1. Past Depression (IV)
Step 2. Additional Illnesses (IV)
Step 3. Number of years wih type 2
diabetes (IV)

Multiple Regression:
Hierarchical Model

What is the relationship between
depression symptoms, glucose control,
and physical function?

SF-36v2 PCS (DV)
BDI-II (IV)
HbA1C (IV)

Multiple Regression: Standard

3. Statistical Analyses Description
A description of the statistical analyses procedure is listed for some of the research
questions needing further detail.
1. Does the method of diabetes medication treatment, oral agent vs. insulin administration,
impact PSS score? Two tailed t-test was used as the statistical method to determine whether
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the method of treatment to control glucose (oral medications vs. insulin use) had an effect in
perceived stress score (PSS).
2. Is there a protective effect of culture on depression symptoms (BDI-II) after controlling for
age education and income? Multiple regressions: Hierarchical model was used to identify the
effect of acculturation in depression symptoms. In the first step, the effect of extraneous
variables (age, education, and income) which has been linked theoretically to influencing the
presence of depression symptoms will be controlled. In the second step acculturation score
was entered to the regression to determine the contribution of this independent variable to the
dependent variable (BDI-II).
3. Do depressive symptoms (BDI-II) mediate the effect of Perceived Stress (PSS) on Glucose
control (A1C)? In order to carry out a meditational effect analysis, a relationship between
BDI-II scores and HbA1C was established. Because no statistically significant relationship
was found between the BDI-II scores and HbA1C, no further testing for mediation was
needed. To test the mediation of BDI-II on the effect imposed by the PSS on HbA1C,
4. Are depression symptoms score associated with past history of depression, reported additional
illnesses, and number of years with diabetes? A Standard Multiple regression was used to
enter in order of believed influence the variables that contributed to the occurrence of
depression symptoms (DV).

Past history of depression, number of additional illnesses

identified by participants, and the number of years with diabetes was entered in the regression
model. Three steps were established with BDI-II scores as the dependent variable. In step
one, past history of depression was entered in the equation; in step two the number of
additional illnesses reported was entered in the equation, and in step the number of years that
the participant reported as having had diabetes was entered. Observation was made of the
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effect added to the equation when each independent variable was entered to determine the
association of BDI-II scores with each of the listed independent variables.
5. What is the relationship between depressive symptoms (BDI-II), glucose control (HbA1C),
and physical function (SF-36v2 PCS)? Multiple Regressions: A standard multiple regressions
was carried out. The independent variables (BDI-II score and HbA1C) were entered into the
regression equation at once. The BDI-II and the HbA1C were evaluated individually to
determine the contribution each adds to the physical function (dependent variable) that differs
from the other variable.
PROTECTION OF HUMAN SUBJECTS
Approval for this study was submitted to the Institutional Review Board of the University
of Texas at El Paso and approval received on November 5, 2009.

An informed consent,

available in English and Spanish, was completed in the participant’s preferred language prior to
participation in the study (Appendix). Restrictions established by the Health Insurance
Portability Accountability Act in accessing medical records and maintaining confidentiality were
followed. All identifiable information was kept confidential and consent forms were number
coded for identification. A logbook identifying the numbers corresponding with each of the
participants’ identifiable information is being kept in a locked file cabinet in the School of
Nursing building, office number 400. This file will be kept for five years after completion of the
study. At the end of this period, records will be destroyed appropriately. The potential risks for
participating in the study were few and included any of the following: (1) becoming fatigued or
nervous while completing the questionnaires, (2) possibility of pain to site during needle stick,
(3) a hematoma at the venous puncture site, and (4) although it is highly unlikely, infection from
the needle stick.
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Prompt action was required to insure the safety of the participant or any other person in
danger. Participants who verbalize any thoughts of suicide or homicide at any time during the
interaction with the RA or PI were to be referred to any of the following community resources
immediately: local MHMR Hotline/Mental Health Crisis Hotline (877-562-6467 or 779-1800),
the police/sheriff officer (911), the nearest emergency room, or psychiatric hospital. The same
prompt action was followed if a participant identifies risk of suicide in question 9 of the BDI-II.
Any participant who answered question two (pessimism) as a high rate, was provided
information for accessing Mental Health Care services available in the community. Any
participant who had problems due to the needle stick was referred to his/her primary health care
provider.
Participants whose HbA1C was ≥9.0% (average glucose equivalent to 240 mg/dL) were
referred to their Primary Health Care Provider for further evaluation within thirty days and a note
attesting to this was completed (Appendix B).
This study provided information regarding the psychological state and of the current
glucose control state of individuals with diabetes. Information gained augments understanding of
the current effect and state of glucose control in Mexican-American individuals with type 2
diabetes and the possible factors predispose to depression symptoms.
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CHAPTER 4
RESULTS
The results of this study are presented by addressing each of the seven questions drafted.
The data were collected from December 1, 2009 to January 31, 2010 with a total of one-hundred
and forty-one participants. The SPSS 17.0 software package was used for conducting the
statistical analysis with collected data.
Research Question One: Analyses of demographics, health history, and scales measured
1. Description of the demographic characteristics of participants.
The majority of participants completed the questionnaires in Spanish (n= 86, 61%) and
most reported Mexico as their country of birth (n= 90, 63.8%). However, a greater number
(n=75, 71.6%) identified themselves as Mexican-American. A large majority of participants
were female and age had a wide range from 18-86 years old. In order to illustrate the age
distribution, Figure 1 presents a graph of age groups represented and its frequency. The
largest portion of participants reported being married (n=70, 50.7%) and the next largest
category were divorced or separated (n=25, 18.1%). Twenty-four reported being widow or
widower (17.4%) and participants who reported being single represented the smallest group
(n=16, 11.6%). Employment status was also reported; those who were retired accounted for
the largest group (n=44, 31.9%) and the smallest group was part-time employment (n=18,
13%). Disability status was reported by thirty-five participants (25%) and those who worked
full-time were in the lower group (n=18, 13%). Twenty- three participants (16.7%) reported
their employment status as housewives.
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Education was calculated based on the self-report of formal years of schooling; there
were three (2.2%) participants who reported no formal education and three with 18 years of
schooling. Formal years of education completed by participants had a wide range of 0-18
years (Median 8, SIR=3.5). This created a positively skewed distribution for its analysis.
However the distribution is also seen as bimodal because six and twelve years of formal
schooling had the highest frequency (n= 24, 17.4%; n=27, 19.1% respectively).
A total of 126 participants (89%) provided income data. The yearly household income
data had a wide distribution; they were positively skewed with a high percentage of participants
reporting lower income in the lower range. Because data collection took place in private primary
care clinics, most participants reported having some type of health insurance/coverage.

A

plurality of participants listed Medicare as a source of health insurance (35.5%), likely due to the
large number of participants 61 years old and older. Thirty (21.3%) participants reported having
dual eligibility for health care coverage by Medicare and Medicaid. Eleven (7.8%) participants
with Medicaid-only health care coverage was the lowest number represented. Twenty-two
(15.5%) participants reported having some type of private insurance coverage. A description of
the continuous variables depicting some of the demographic information and two of the
components of the health history reported by the participants is listed in Table 2. The additional
chronic illnesses, total of eight, were selected by the participants from a list provided which
included: arthritis, depression, high blood pressure, high cholesterol, heart disease, stroke, kidney
disease, and poor circulation.
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Figure 2. Age Groups Distribution (N=141)

Table 2. Participants’ Information
N

Range

M(SD)

Median (SIR*)

Age

141

18-86

62.4 (13.5)

64(9.5)

Formal Education

138

0-18

8.2 (4.4)

8(3.5)

Household Income

128

$4,200-88,000

$17,286 (16,508)

$11,430 ($5,206)

Years with Diabetes**

139

1-45 yrs.

10.3 (9.4)

8(5.5)

0-8

3.1 (1.5)

3(1.0)

Additional Chronic Illnesses
139
*Semi-interquartile range. **type 2 diabetes

2. Description of health history components and treatment method.
In this section, the results of the variables describing components of the health history for
this research are presented. All information included in the analyses was obtained from the
demographic questionnaire which was the participants’ self-report.
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One hundred and thirty-nine participants reported the number of years since diagnosed
with type 2 diabetes. A wide distribution, positively skewed, was noted with the number of years
ranging from 1-45 with a median of eight years (SIR=5.5). The majority of the participants
described taking medications for diabetes management (n=121, 86%). Participants were asked to
list all medications that they were taking and only one hundred and twenty-two responded
(86.5%) to this question. The number of diabetes medications reported by participants ranged
from 1-4 types with the average being 3 medications. Forty-two participants (30%) reported
insulin use for diabetes management.
One hundred and thirty-eight of the participants acknowledged having additional
illnesses with diabetes, identified from a list of nine conditions with the option to enter additional
conditions. The number of additional illnesses ranged from one to eight with an equal
distribution (M=3, SD=1.5). The most common chronic illness reported was high blood pressure
(n=108, 77%), followed by high cholesterol (n=89, 63%), and problems with circulation (n=51,
36%).

The number of additional illnesses ranged from one to eight with an average of three

illnesses per participant.

The most common chronic illness reported was high blood pressure

(n=108, 77%), followed by high cholesterol (n=89, 63%), and problems with circulation (n=51,
36%). In the reported medical history, forty-two participants (30%) recalled being informed that
they had depression. Additionally, thirteen participants (9.2%) reported taking antidepressants.
Table 3 describes further demographic data and the components of the health history that
were obtained as a dichotomous response. A greater representation of females is noted and
approximately two-thirds of the participants were born in Mexico. The majority of participants
reported exercising on a regular basis. The percentage of participants who reported having had
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depression in the past (31.6%) was only slightly lower than the total number of participants in
this study who scored in the mild to severe range level of depression symptoms score (34.8%).

Table 3. Demographic and Health Information of all Participants (N=141)
n
Valid Percent
GENDER
Male
49
34.8%
Famale
92
65.2%
Missing
0
BIRTH COUNTRY
Mexico
90
64.7%
USA
49
35.3%
Missing
2
1.4%
HEALTH INSURANCE
Yes
118
84.9%
No
21
15.1%
Missing
2
1.4%
INSULIN USE
Yes
42
30.7%
No
95
69.3%
Missing
4
2.8%
EXERCISE
Yes
99
70.2%
No
42
29.8%
Missing
0
HISTORY OF DEPRESSION
Yes
42
31.6%
No
91
68.4%
Missing
8
5.7%
Note. History= reported being identified by a health provider as having depression

3. Description of glucose control and measured scales.
In this section a description of the results obtained from the glucose control and all the
scales included in this study. A summary is included in Table 4. One hundred and thirty-eight
HbA1C results were available for analyses. The HbA1C ranged from 4.0 to 15.9% with a mean
of 7.8% (SD=1.9%). The mean score exceeds the national recommendation of ≤7.0%
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established by the ADA (2010). The results were well distributed with four outlier scores
representing HbA1C between 12.5 and 15.9%.
The depression symptoms score (BDI-II) distribution was positively skewed with the
majority of participants (n=92, 65.2%) scoring in the minimal depression range which is a score
of 0-13. Figure 2 shows the four groups of scores created to illustrate the results of all scores
represented; depression symptoms score ≥ to 13 is considered a likely occurrence of clinical
depression.
The results of the perceived stress scale (PSS) was in the mid range level of the scale, the
higher the score the greater the perceived scale. The scores of the physical composite scale
(PCS), which is addressed as physical function, were well distributed and results were above
the norm base level of 50 which is considered to be in the positive range of health state (Ware &
Kosinski, 2001).
The scores of the acculturation scale created a positive skewed distribution with majority
of participants (n=60, 42.6%) reporting a score of zero which indicates that Spanish is the
dominant language in this population. This information goes along with the finding that the
majority of the participants in this study selected the questionnaires in Spanish.
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Figure 3. Depression Symptoms (BDI-II) results (N=141)
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Table 4. Results of Questionnaires and Glucose Control
Variable
N
Range
M(SD)
Median (SIR)
HbA1C

138

4-15.9%

7.8% (1.93)

7.2%(1.85)

BDI-II

141

0-36

11.5 (5.7)

9(6.5)

Acculturation

141

0-20

4.9 (5.7)

2(4.7)

PSS

141

0-45

23.7 (7.9)

25(4.5)

PCS

139

5-100

56.17 (28.3)

60(25)

Note. HbA1C: glucose control level; SIR: Semi-interquartile range; BDI-II:
Beck Depression Inventory Index-II; PSS: Perceived Stress Scale; PCS: Physical Health Scale.

4. Inferential Statistics of demographic variables, health history and measured scales.
Initial analysis was conducted to gain information on the relationship that gender has
with all the participants’ demographic and health information listed in Table 2. A Chi-square
test of independence was carried out. Statistical significance was identified only in the
relationship between history of depression and gender (χ ² (df=1) = 7.129, p<0.05). This
means that a history depression is related to the person’s gender, specifically female. Table 5
lists the results of the conducted analysis by gender. There was not a statistically significant
result in having health insurance, insulin use, or whether they exercise. This means that the
above variables were not related to the person’s gender.
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Table 5. Relationship between gender and listed demographic
and health variables by Pearson Chi-Square (χ²) analysis
`Gender
χ²
Variable
Male
Female
n
%
n
%
Health Insurance
1.419
Yes
44
89.8%
74
82.2%
No
5
10.2%
16
17.8%
Insulin Use
3.212
Yes
19
40.4%
23
25.6%
No
28
59.6%
67
74.4%
Exercise
1.934
Yes
38
77.6%
61
68.3%
No
11
22.4%
31
33.7%
History of Depression
7.129*
Yes
8
17%
34
39.5%
No
39
83%
52
60.5%
Note. *p=<.05
Evaluation of the effect of demographic variables, years with type 2 diabetes, and the
various questionnaires/scales completed by participants was carried out to gain further
understanding of the effect on HbA1C and BDI-II scores which are the major variables of
interest for this study. Pearson correlations were conducted to evaluate the relationship among
these variables. The description of the included variables and the results are presented as a
correlation matrix in Table 6 and description of statistically significant results are presented.
Age had significant negative correlation with years of formal schooling, PSS,
acculturation score, and PCS. In this study sample, older persons had less years of formal
education, less acculturation to U.S. culture, and lower physical health scores. Younger persons
had higher perceived stress level scores. A positive correlation was noted between age and time
with diabetes. A positive significant correlation was identified between age and years with type
2 diabetes; the older the person the longer they had had diabetes.
Education had a significant positive correlation with income; those reporting more years
of formal education also reported higher income. Additional positive correlations with education
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were perceived stress and acculturation. Greater years of schooling were related to higher
perceived stress and acculturation scores.
The reported yearly household income had a significant positive correlation with
acculturation and perceived stress; higher income was related to greater acculturation to U.S.
culture and to higher perceived stress scores. Age had a significant negative correlation with
yearly household income; the older the person was the lower the yearly household income.
The reported number of years with type 2 diabetes had a significant negative correlation
with the physical health scale. Longer period of time with diabetes was related to having a
physical health score lower than U.S. norm.
A significant positive correlation was identified between the BDI-II and Perceived Stress
Scale (PSS) (r=.402, p=<.001). In this group, as stress level increases the presence of depression
symptoms increased. A significant negative correlation between depression symptoms (BDI-II)
and the physical health component scale (PCS) of the SF-36v2 was identified (r=-.247, p<.05).
This indicates that in this sample, higher score of depression symptoms are associated with lower
physical health. The HbA1C did not correlate significantly with any other measured variables in
this study.
The physical health scale (PCS) had a negative correlation with perceived stress level.
The higher the level of stress reported the lower the score in physical health.
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Table 6. Correlation Matrix of Participants’ Information and Scales’ Score
Variable
1. Age
2. Education
3. Income
4. Years with
type 2 diabetes
5. HbA1C
6. PSS
7. BDI-II
8. Acculturation
9. Physical Health

1

2

3

4

5

6

7

8

9

1.00
.170

1.00

1.00
-.444**

-.308**
.278**

1.00
.446**
-.076

1.00
-.129

1.00

-.061
-.168*
-.127

.154
.217*
.001

-.117
.070
-.112

.107
-.011
.072

1.00
.043
.059

1.00
.492**

1.00

-.403**
-.236

.740**
.164

.523**
.222*

-.068
-.201*

.088
-.075

.213*
-.211*

-.049
-.247**

Note. HbA1C=long-term glucose control; PSS=Perceived Stress Scale; BDI-II= Beck Depression Inventory IndexII. *p<.05. **p<.01.

Further evaluation of HbA1C and BDI-II was carried out using an independent group
t-test to determine if nominal variables such as gender, insulin use, and participants’ report of
whether or not they exercise predict differences in HbA1C and BDI-II. The mean values indicate
that those who use insulin have a higher HbA1C (M=9.033, SD= 2.229) than those not using
insulin as part of diabetes treatment (M=7.268, SD= 1.530). Results indicate a statistically
significant difference between insulin and non-insulin treatment samples in the HbA1C,
t(df=132)=5.332, p<.001. The BDI-II did not differ significantly as a function of the variables
evaluated.
The HbA1C results were further divided into two categories: controlled (4.2 to 6.9%) and
uncontrolled (7.0 to 15.9%). The percentage of participants who had a controlled glucose was
37.7% (n=52), However, 62.2% (n=86) were in the uncontrolled level which places individuals
at a greater risk for developing complication such as microvascular (renal and ophthalmic)
disease,

macrovascular (cardiovascular) disease, and neuropathies (loss of limbs). The

recommended level for HbA1C is ≤ 7.0% (ADA, 2010).
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Research Question Two: Does the method of diabetes medication treatment, oral agents vs.
insulin administration, impact PSS score?
Information was obtained using the self-report method for participants to identify
whether they were using insulin to control their glucose. A dichotomous (yes/no) response was
recorded and analyzed as an independent variable along with the total score of the Perceived
Stress Scale (PSS) as the dependent variable.
The statistical analysis conducted was an independent t-test to determine the mean
difference in the total PSS score between the group of participants who reported insulin use and
the ones who did not use insulin. Most participants reported taking oral medication to control
their diabetes. Approximately one out of every three participants reported using insulin as part
of diabetes treatment. The mean values indicate that the PSS score of those using insulin as part
of their diabetes treatment (M= 23.17, SD=8.65) was very similar to those not using insulin (M=
23.95, SD=7.69). There was no statistically significant difference between these two groups
(t(135)= -.527, p=.599).
Research Question Three: Is there a protective effect of acculturation on depression
symptoms (BDI-II) after controlling for age, gender, education, and income?
Hierarchical multiple regression analysis was carried out to test the effect of acculturation
on the respondent’s total depression symptoms score. Two-step analyses were carried out with
BDI-II as a dependent variable and acculturation as the independent variable. Respondents’
demographic variables included in the model were age, gender, education, and reported yearly
household income.
In the first step, the set of demographic variable is entered. In step two, acculturation was
added to the list of demographic variables already included in step one. Results of step one
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demonstrate that demographic variables accounted for 3.1% of the variance in depression
symptoms. The addition of acculturation to the set of demographic variables in step two led to
an R² change of <1%. This reflects that adding acculturation did not add significance to the
model as reflected by the F change (.869). The results suggest that acculturation did not add
more power to the predictor set then the demographic group. The addition of acculturation did
not predict depression symptoms in this model. Table 7 describes the steps and equation model
used for addressing this question.
Table 7. Summary of Hierarchical Multiple Regression Analysis
for Predictors of Depression Symptoms (BDI-II) (N=141)

Step 1
Age
Gender
Education
Income
Step 2
Age
Gender
Education
Income
Acculturation

R²
.031

.032

∆R²
.031

.001

∆F
.966

.027

Sig ∆F
.429

β

p

-.124
.046
.027
-.161

.227
.614
.805
.116

-.126
.043
.769
-.156
-.025

.225
.646
.769
.148
.869

.869

Research Question Four. What is the association between depression symptoms and long
term glucose control?
Pearson correlation analysis was carried out to determine the association between these
two continuous variables. There was no statistically significant correlation between depression
symptoms and HbA1C level r(136)=0.06, p=.490. This means that no association was identified
between participants’ depression symptoms score and the HbA1C levels.
Research Question Number Five. Do depression symptoms mediate the effect of Perceived
Stress on HbA1C?
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Because no main effect for depression symptoms on HbA1C was found, the BDI-II
clearly does not act as a mediator in this case. Additionally, there was no effect for the PSS on
HbA1C results. To address this question, a correlation was first carried out between BDI-II and
HbA1C to determine statistical significance that would determine the mediation effect of PSS
once included in the equation. There was no statistical significance identified between BDI-II
and HbA1C r(136)=.059, p=.494. Correlation was further examined between HbA1C and
Perceived Stress (r(136)=.043, p=.616). The results in this study do not reflect a relationship
between PSS score and HbA1C.
In this study, the long term glucose control does not seem to be related to depression
symptoms score or perceived stress scores.
Research Question Number Six. Is time with type 2 diabetes associated with depression
symptoms, independent of history of depression and presence of other illnesses?
A hierarchical multiple regression analysis was carried out between the dependent
variable (BDI-II) and the independent variables which are components derived from the medical
history: reported past history of depression, total illnesses in addition to diabetes, and number of
years with type 2 diabetes. The total illness variable consisted of self-report of additional illness
which included a total of nine conditions. Three steps were set up to determine a predictor model
for depression symptoms based on the health history variables.

Table 8 summarizes the

description of the model and its results. Step one show that history of depression account for
8.2% of the variance (R²) in depression symptoms. Step two shows that when the participant’s
additional illness is added to history of depression the variance in depression symptoms
increased to 8.7%. In step three the final health history, years with type 2 diabetes, was added
and accounted for an increase of 8.8% of the variance in depression symptoms. The model (step
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three) resulted in an R² change of .001. The standardized regression coefficient (β weight)
demonstrates that past history of depression was the independent variable that had the greatest
influence in the prediction of depression symptoms severity (BDI-II scores) thus making the
overall model statistically significant for predicting depression symptoms .
This same equation analysis was carried out with HbA1c as a dependent variable and no
statistical significance was identified (R²=.01, p = .713).
Table 8. Hierarchical Multiple Regression Analysis Predicting Depression
Symptoms with Medical History Components (N=141)

Step 1
History of
Depression
Step 2
History of
Depression
Additional Illnesses
Step 3
History of
Depression
Additional Illnesses
Years with Diabetes
**p<.001

R
.082**

.087**

.088**

∆R²
.082

.005

.001

∆F
11.38

.656

.098

Sig ∆F
.001

β

p

-.287

.001

-.282

.001

.042

.626

-.254

.008

.028
.070

.754
.476

.419

.754

Research Question Number Seven. What is the relationship between depression symptoms,
glucose control, and physical function?
A standard multiple regression analysis was performed between the dependent variable,
physical function (PF) as measured by the SF-36 v2 ,which is a scale used to measure quality of
life, and the independent variables depression symptoms (BDI-II), and glucose control (HbA1C).
Regression analysis revealed that the model was statistically significantly in predicting physical
health (p=.01). Table 9 summarizes results of the variables included in the regression. The
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results indicate that the depression symptoms score has more of an influence in the statistical
model that predicts physical function scores, Beta weights (β)= -.240, p= .005, than the glucose
control as observed by the results of the analysis. In this population, the drafted model of
depression symptoms score and the glucose control level are predictors for the person’s physical
health score.
Table 9. Multiple Regression Analysis Predicting Physical Health (N=141)

Constant
BDI-II
HbA1C
R²=.063, p=<.05

B
71.503
-.732
-.889

SE B
10.18
.256
1.228
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β
-.240
-.061

p
<.01
.005
.470

CHAPTER 5
RESEARCH DISCUSSION
Results of this study and its implications for provision of health care for Mexican
American individuals with type 2 diabetes are discussed in this chapter. Detailed discussion of
the results is presented by research question.
Demographic characteristics
Research question one examined the demographic characteristics of all participants. The
age range of this sample population was 18-86 years of age (Mean=62.4, SIR=13.5) creating a
negatively skewed sample distribution. The presence of such high percentage of older persons
posses an opportunity for comparing this study’s findings to the Hispanic Established
Populations for the Epidemiological Studies of the Elderly (HEPESE) which is the largest
retrospective study of older adult community residents representing all Southwest states that
evaluated the health conditions and functioning of older adults (Black, 1999). The HEPESE
study is where most information on the presence of diabetes and depression was obtained and
published (Black, 1999; Black, Markides, & Ray, 2003). The mean age observed in this study is
representative of the country’s prevalence of type 2 diabetes in the 60 years old or older group
where 23.1% is estimated to have type 2 diabetes (CDC, 2007). Results of this study differ from
the previously reported information of El Paso County with data collected in 2002 from the
Behavioral Risk Factor Surveillance System (BRFSS). The mean age reported in that survey
was 53.7 years old (SD= 2.1) (Martinez & Bader, 2007).
The prevalence of older age may have accounted for “retired” employment status being
the largest group represented in this research. Because a large portion of participants were older
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and retired, they were also eligible for Medicare health care benefits and able to seek health care
services from private family care clinics for their health care needs.
Women had a greater representation in this sample, 65.2%, than men. The representation
of women at a much greater scale than men supports the publication of Robinson (2007) which
describing older women as a majority of the older population. Additionally, in general women
are more likely to visit a health care provider (DHHS, 2007) than men. Majority of participants
of studies included in the literature review had greater representation of females (Black et al.,
2003; Egede & Zeng 2003; Lustman, 2000; Mier et al., 2008) which is similar to the findings of
this study. The study by Pineda-Olvera et al. (2007) is one of the few prospective studies that
evaluated presence of depression in a public health clinic setting. However, this study was
exclusively in Hispanic women whose largest group was of Mexican descent. One of the most
recent studies conducted along the U.S./Mexico border on Diabetes and Depression also had
greater representation of females in U.S. and Mexico side (Mier et al., 2008).
The results of the education variable were interesting sine the distribution was bimodal
with sixth grade and twelve grade education reporting the highest frequency of completed
education years. This leads to the conclusion that in this study there was a good representation
of those that were and those that were not formally educated. However, the majority had less
than high school education level. This group represented a less educated group in comparison to
the rest of the El Paso County, Texas which reports a 65.8% of residents 25 years of age and
older having a high school education (U.S. Census, 2010). The factors that may have influenced
the results in this study is the age of the participants along with the age of migration to U.S.
which ranged from 1-65 years old (Median=24, SIR= 17). In the HEPSE study, participants
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were 75 years and older and large majority also migrated at a young age, formal education was
reported as less than 6 years (Black et al., 2003).
The majority identified Mexico (64.7%) as their country of birth. Most participants
elected to answer study questionnaires in Spanish ( 61%) and adaptation to U.S. culture levels as
measured by the Acculturation Scale (Marin et al., 1987) was low (Median=2, SIR=4.7).
The median household income identified in this study (Median= 11,430, SIR=5,206) is
much lower than the median of $38,779 for Hispanics in the U.S. (US Census Bureau, 2007) and
also lower than the $36,519 reported for El Paso County in 2008 (US Census Bureau, 2010). A
large portion of the population reported a “disabled” status when asked to identify employment
status. This information along with the presence of a large number of older adults may have
contributed further to the low income reported by this sample population. Because of the low
income levels reported by participants, many (21%) also had Medicaid health services coverage
to supplement Medicare coverage. This created a unique sample group that supports the reason
for participants’ ability to select private family care clinic for provision of health services.
The personal information reported by participants’ parallels publications that describe
Mexican Americans as having lower educational level and income compared to the rest of the
US population (Livingston et al., 2008). Because the data collection was conducted in private
clinics a large majority of participants had some type of health insurance, only 16% did not have
health insurance as compared to the 36.2% Mexican Americans in the U.S. (Rhoades & Vistnes,
2006).
Participants’ Health History
The HbA1C mean for this sample was 7.8% exceeding the recommendation of
≤6.5%- 7.0% (ADA, 2009; AACE, 2007); levels above 7.0% which equate to glucose 70-130
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mg/dl have been found to increase diabetes complications (ADA, 2009). The wide span of time
reported since diagnosed with diabetes, median of 8 years (SIR=5.5), and the HbA1C above the
recommended levels places individuals at higher risk for diabetes complications (ADA, 2009).
The Pineda-Olvera study did not provide HbA1C results which is the study that correlated
glucose levels with depression symptoms. A recent study by Fisher, Glasgow, & Strycker,
(2010) evaluated the relationship between diabetes distress and clinical depression with glycemic
control in a longitudinal study. The reported HbA1C had a M=7.2 % (SD= 1.44%) and the
number of additional illnesses with type 2 diabetes had a M= 3.9 (SD= 2.5). Results of this study
demonstrate a higher HbA1C level and similar number of additional illnesses. The differences in
the results between these studies are minimal which may point to similar patterns of participants
included. The Pineda-Olvera et al. (2007), which included all Latino participants, reported less
time with type 2 diabetes with a M=7.64 years (SD=6.30) and were a younger population with a
M=51.82 years old (SD= 8.73). The participants in the Mier et al. (2008) study conducted in a
binational between U.S. and Mexico border populations reported a mean of 11 years (SD=10)
with type 2 diabetes in those residing in the U.S.
The depression symptoms score measured by the BDI-II describes the possibility of
clinical depression at four levels. Score of 0-13 is considered minimal depression symptoms
score, 14-19 is described as mild, 20-28 is moderate, and scores of 29 or greater is severe level of
depression symptoms score (Beck, Steer, & Brown, 1996). The depression symptoms score and
the frequency obtained in this research included: sixty five percent of participants (n=92) scored
in the minimal level of depression symptoms, 14.2% (n=20) in the mild range, 12.8% (n=18) in
the moderate range, and 7.8% (n=11) in the severe range. Those participants whose score was in
the moderate to severe range were referred to mental health services on the day of the interview.
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The summative prevalence of depression symptoms from mild to severe is 34.8% which is
higher than previous reported studies (Black, 1999; Black et al., 2003; Pineda-Olvera et al.,
2007). In an exploratory study conducted in El Paso County colonias, individuals who self
reported having diabetes also reported a 20% prevalence of depression. This report was based on
disclosure of having been told that they had depression. No screening tool was used to assess
depression (Solis, Wiebe, & Anders, 2008). The possibility of a higher reported incidence of
depression in the participants in this study may be due to following factors: lower socioeconomic
status (SES), majority was female, and an older population group. The NIMH (2008) describes a
higher prevalence of depression in Hispanic females and in elderly. Low education levels usually
associated with lower income levels have been identified as risk factors for depression in
Hispanics (NIMH, 2008; Shmaling & Hernandez, 2005).
The score of physical health scale of the SF-36v2 are norm based measures and
participants in this study measured slightly above average, M=56.16 (SD= 28.3).
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considered average according to U.S. Norm (Ware & Kosinski, 2001). Participants reported
above average scores and differ from results of other published in other studies where Mexican
Americans constituted a small portion of the population. Physical well-being of individuals with
diabetes have been reported as decreased compared to non-diabetic individuals (Golden, Lazo, &
Carnethon, 2008; Katon, 2008, Lee et al., 2009).
Inferential Statistical Analyses
Chi-Square Analysis (χ²)
The relationship identified during the Chi-square analysis between gender and history of
depression is not a surprising finding. A greater prevalence of depression has been reported in
females in the general population with rates doubled than men across ethnic groups (NIMH,
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2008).

In the Mier et al. (2008) study of diabetic individuals with depression, a greater

prevalence of depression among females was identified. The HEPESE studies conducted in
elderly Hispanic community residents also reported a higher prevalence of depression among
female participants (Black et al., 2003; Gross et al., 2005; Sacco et al., 2007).
Correlations
The variables related to depression symptoms (BDI-II) were physical health (PCS) and
perceived stress (PSS). Physical health declined with the presence of depression symptoms.
This information is supported by other studies (Mier et al., 2008; Lee et al., 2009; Schneider,
2006) which acknowledge that physical state is affected by the presence of depression. One of
the requirements for diabetes management is to maintain and, at times, augment physical activity
to maintain glucose level as near normal as possible and to guard against diabetes complications
(ADA, 2010). Thus the presence of depression symptom in individuals with type 2 diabetes may
affect their adherence to exercise.
Higher depression symptoms score was correlated with PSS scores. Individuals with
higher perceived stress scores are more likely to have a higher prevalence of depression
symptoms.

This finding supports the theory that stress level predisposes individuals to

depression symptoms (Delahanty et al., 2007). The physical and emotional stress experienced by
individuals with diabetes has been addressed in other studies as contributing factors to
depression (Anderson et al., 2000; Black, 1999; Black et al., 2003; Golden, Lazo, Carnethon,
2008; Katon, 2008).
Education and perceived stress score achieved a positive correlation with statistical
significance; this indicates that the higher the number of school years completed the higher stress
level. These findings vary from some of the literature regarding social determinants of health.
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According to Griffith & Villavicencio (1985) education has been recognized as a strong indicator
of socioeconomic status measure and influences health behaviors. Consequently those of with
higher education report better health state and in contrast, those with lower education report less
health and stress has been seen as part of the health component (Finch, Kolody, & Vega, 2000).
Ethnic minorities have reported a stress level higher than those not considered a minority
(Griffith & Villavicencio, 1985).
However, in a similar study the correlation among education and stress was evaluated by
Spencer et al. (2006) among Hispanics and African Americans with type 2 diabetes in the Detroit
area; no statistically significant correlation was identified between the two variables. The authors
identified that the limitation in that study may have been that the participants were a convenience
sample from a health clinic that had full patient support.
It is possible that the findings of positive correlation between education and stress
identified in this study may have had to do with the mid distribution range of the stress score as
well as the reported years of education reported a bimodal effect. It creates an area for further
exploration.
The lack of correlation identified in the HbA1C among the same variables, as those with
the BDI-II, demonstrates a difference from previously published studies where a correlation had
been identified between depression and glucose control (Pineda-Olvera et al., 2007; Gross et al.,
2005; Lee et al., 2009). This may be that the HbA1C reported in those studies was obtained
from the medical record. The HbA1C in those studies was obtained from 12 weeks to 6 months
prior to data collection. In this study, the HbA1C serum test was obtained at the same visit of
data collection.
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Glucose control analysis
The HbA1C results were further analyzed to gain understanding of its role in this study
since no statistically significant correlation was identified with the scales used in this study or
with demographic characteristics of the participants.
The HgA1C level was found higher in individuals that reported using insulin as part of
their diabetes management.

This finding is unexpected as American Diabetes Association

(2010) recommends insulin therapy administration as part of the medical treatment when
diabetes is not controlled with oral medications in order to achieve the ≤7.0% HgA1C (ADA,
2010). Therefore insulin is the most effective treatment for glucose control. A comparison of
medication use pattern of the HEPESE older adults from 1993-1994 and again in 2004-2005
conducted by Beard et al. (2010) demonstrates a decrease in insulin use from 21% in 1993-1994
to 7.5% in the 2004-2005. The reasons described for this change include a decrease of insulin
use as the only method of treatment in 1993-1994 to taking two or more diabetes medications of
newer classifications thus decreasing the need for insulin use.

Information on number of

medications being used to control glucose was not asked in this study and thus no explanation
available to determine reasons for the obtained result in this study. The percentage of participants
who use insulin to control glucose was 30.7% (n=42) which means that approximately one out of
every three persons with type 2 diabetes in this study uses insulin as part of their diabetes
treatment. This was lower than the 36.4% (n=20) reported in the study by Lee et al. (2009).
There was no effect on BDI-II when comparing insulin and non-insulin users. This is similar to
the findings by Lee et al. (2009) where depression was not related to any treatment modality.
The number of participants with uncontrolled type 2 diabetes (HbA1C >7.0%) found in
this study was higher than those found in the Lee et al. (2009). However, the participants in this
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study were older and had been diagnosed with diabetes longer. This may account for the
differences between these two studies.

This also presents the possibility of diabetes

complications increasing among participants in this study.
Glucose levels may be influenced by lack of sufficient financial resources to purchase
non-covered medical treatment and also to have the resources for purchasing healthy foods.
Glucose control is highly affected by adherence to prescribed treatment. In the HEPESE study by
Yong-Fong et al. (2003), 36% of participants were determined to be inconsistent with their
treatment due to older age and no supplemental insurance to cover treatment. The presence of
additional illnesses existing with type 2 diabetes may also affect the glucose level (ADA, 2010).
Research Question Two:
The stress level associated with the personal demand placed on individuals with type 2
diabetes was thought to be an underlying variable that contributes to depression in this
population. In this study, the Perceived Stress Scale was used to evaluate whether stress level
contributed to the depression symptom score.

The results with this population negate the

association between stress and depression symptoms which had been alluded to in other studies
(Katon, 2008). The findings in this study also differ from those found in the study by Spencer et
al. (2006). In that study, Hispanics were from the Detroit, Michigan area and the perceived
stress was measured by two scales: the Cohen’s perceived stress scale- 4 item (PSS-4), and ten
questions from an adapted scale from Hazzles and Uplifts. Spencer et al. (2006) found stress to
be correlated with psychosocial components such as the person living alone, as well as with
diabetes activities which was measured by the PAID (Problem Areas in Depression) which has
been widely used in individuals with diabetes. The health history of participant’s was not
included outside the self-report of diabetes and a retrospective review of the medical record to
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identify the last HbA1C recorded within the past 12 months which was not found to contribute to
stress score.
Research Question Three:
The effect of acculturation was evaluated as a protecting factor for depression symptoms.
In this study, acculturation did not have any effect for predicting depression symptoms. The
factors that may have contributed to this finding could be that the participants’ acculturation
level reported was in the low range with scores ranging from 0-20 (Median= 2, SIR= 2.7).
Spanish usage was the most common language identified by participants. Additionally, plurality
of participants identified Mexico as their birth country and currently resides in a predominantly
Mexican-American community in the U.S. where 73.3% of the population (U.S. Census, 2010)
speaks a second language with Spanish being the most common. The factors mentioned create
homogeneity in the sampled population and may have been a contributing factor for
acculturation not having any predictive effect on depression symptoms.
Depression in Hispanics, which Mexican-Americans are considered a majority, has been
identified to be more prevalent among individuals with greater acculturation level (NIMH,
2008). However a study conducted by González, Haan, & Hunter (2001) on the prevalence of
depression in older Mexican Americans, based on acculturation level, and had different results
than the information from NIMH (2008).

In the study by González et al. (2001) participants

who had a lower acculturation level reported a higher risk of depression as measured by the
Center for Epidemiological Studies Depression Scale (CES-D).

The authors measured

acculturation by a more extensive questionnaire, 19 items, modified from the Acculturation
Rating Scale of Mexican Americans (ARSMA-II). Participants born in Mexico constituted 34%
of the sampled population in the González et al. (2001).
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The results obtained in this study and those by González, Haan, & Hunter, (2001) provide
insight into the complexity of acculturation. It is a factor that would need to be evaluated in a
more heterogeneous group to have a greater distribution of scores and gain variability to make
appropriate recommendations.
Research Question Four:
There was no association identified between depression symptom score and glucose
control level. The evaluation of these two variables was a major impetus for this study. However,
because no statistically significant association was found among these two variables, it is likely
that the reason for this outcome may be multi-factorial. Factors that need to be considered
outside the two tested variables may be both personal and socio-economic characteristics that
may protect or increase vulnerability to depression symptoms.

This study did not support the

previous studies (Lustman et al., 2000; Pineda-Olvera et al., 2007) where glucose levels were
related to presence of depression. The presence of a support system to assist individuals with
type 2 diabetes cope with this chronic illness has also been recognized as an important influence
in glucose control and as a guarding off factor for depression symptoms in individuals with type
2 diabetes (Lustman et al., 2000) , or existing co-morbidities. Greater depth of exploration of the
phenomena of depression symptoms in individuals with type 2 diabetes and its effect on the
psychological state of affected individuals needs to be considered.
A recent secondary analysis study by Rush et al. (2008) (N=1223) evaluated whether
depression symptoms were related to being able to achieve nationally recommended glucose
control levels. The reported glucose levels were obtained from a result within the year when data
were collected. The depression symptoms score was obtained from the PHQ-2 screening for
depression that asks the following two questions: 1) during the past month have you been
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bothered by feeling down, depressed, or hopeless? 2) During the past month, have you often
been bothered by little interest or pleasure in doing things? (Rush et al., 2008, p. 393)
The findings identified that individuals with greater prevalence of depression symptoms
were less likely to be at the recommended glucose control level. The actual measurement of
HbA1C at time of data collection provided a more timely actual glucose control result as
compared to other studies where it was obtained from weeks to months prior to data collection
(Pineda-Lover et al., 2007; Fisher et al., 2001). This may have been an added factor for not
finding statistically significant results between depression symptoms and glucose control.
Research Question Five:
A question was drafted to evaluate whether depression symptoms mediate the effect of
Perceived Stress Score on HbA1C. Stress level in individuals with DM has been described as a
precursor to depression thus affecting metabolic function (Golden, 2007).

The conceptual

framework drafted for this study perceived stress was considered to be a factor that predisposed
individuals with DM to depression symptoms and affected glucose control.
In this study, the lack of a significant relationship between depression symptoms score
and glucose control stopped the continuation for evaluating BDI-II as a mediator of perceived
stress and glucose control. Perceived stress did not have a statistically significant association
with glucose control. The effect of perceived stress would need to be evaluated further to
determine its association with depression symptoms and demographic characteristics of study
participants. It is possible that the scale used to measure stress might not be sensitive enough for
population such as the one included in this research. The PSS-14 item used in this study had
been validated in Mexican population who were younger and with college education level.
Because of the many self-care tasks that diabetic individuals have to carry out as part of disease
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management, a stress scale that evaluated some of these factors might have been more sensitive.
Such instrument to consider is the Problem Areas in Diabetes (PAID) by Polonsky, W.H., et al.
(1995) which measures emotional stress related to diabetes.
Research Question Six:
Components of the medical history of participants demonstrated that the strongest
predictor for depression symptoms in individuals with type 2 diabetes was past history of
depression. This finding is significant for clinicians as the presence of depression influence the
progression of chronic illness and leads to worsening of perceived health state and physical
function (CDC, 2007; Black, Ray, & Markides, 1999). Additionally, all these factors increase the
utilization of health care services.
Depression has been acknowledged to be a factor that increases the possibility for
developing heart disease (NIH, 2010). Individuals with type 2 diaetes are also at increased risk
for macrovascular complications which includes heart disease (ADA, 2010). Therefore
individuals with DM2 who also have depression have an even greater incidence of heart disease.
This information may be the basis for identifying a greater morbidity and mortality addressed by
Lustman et al. (2000) in the study of Mexican American individuals with diabetes and
depression.
The clinical significance of this finding is the need for proactive approach to treatment of
individuals with type 2 diabetes.

Clinicians need to probe into mental health history of

individuals served and be vigilant of the reoccurrence of depression. Because type 2 diabetes is
a chronic medical condition, efforts must be taken to prevent development of additional illnesses
to lessen the risk of depression. The longer the person has diabetes the greater the possibility for
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developing depression symptoms (Lustman, & Clouse, 2005). Clinicians must be alert to this
information and screen for depression on a timely matter.
Research Question Seven:
The effect of depression symptoms and glucose control on physical function as measured
by the PCS (Physical Composite Scale of the SF-36v2) was evaluated. This was drafted as a
variable to measure a component of Quality of life. This study identified Glucose control
(HbA1C) and depression symptoms (BDI-II) as predictors of physical function in a standard
multiple regression analysis that was statistically significant. This information partially supports
the drafted conceptual framework for this study as it had been drafted with physical function
acting as bidirectional with depression and glucose control.
This finding supports previous study by Lee et al. (2009) where physical health summary
scores were found to be worse on individuals with greater depression symptoms than those with
less depression symptoms.
Individuals with diabetes, especially older adults, have a decline in physical function. In
this study physical function did not affect glucose control but did have a relationship with
depression symptoms. Even when glucose is not affected, quality of life of individuals with
depression symptoms is affected with influence in physical function.
The implication for clinicians is that physical activity is part of diabetes management and
may influence other physiological functions even when glucose is not directly affected. This
study provides insight into the relevance for addressing depression symptoms screening and treat
individuals with type 2 diabetes in a holistic manner to maintain a quality of life acceptable for
the individual.
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CHAPTER 6
CONCLUSIONS
The purpose of this study was to evaluate presence of depression symptoms and its
relationship with glucose control.

Although no statistical significance was found in the

relationship between glucose controls (HbA1C) and depression symptoms (BDI-II), important
information emerged as potential metabolic and psychological risks factors that this population
may face due to their personal characteristics and health history.
In this study, the BDI-II played a major role in its relation to several variables. The BDIII was found to be related to perceived stress and physical function. The medical history
components evaluated were found to be related to BDI-II scores. There was no direct
relationship, positive or negative, with demographic variables but the perceived stress scores
were related to age, gender, education, and acculturation which creates a question as to whether
stress may eventually play a role in the development of depression symptoms. The physical
health score from the SF-36v2 were related to perceived stress score and affected by the
combination of BDI-II and HbA1C. These findings demonstrate that individuals with diabetes
have potential psychological conditions such as stress and depression that need to be addressed
during the course of the disease. This is especially true because of the need to maintaining
mobility, through regular exercise, is an essential component of the self-care management for
type 2 diabetes.
This research provided significant information of a segment of the U.S. population that is
highly affected by type 2 diabetes. Glucose control level based on HbA1C is considered the gold
standard for identifying individuals with diabetes who may be at greater risk for developing
complications of this metabolic condition. In this study, the majority of the participants had a
64

HbA1C greater than the 7.0% which classifies the diabetic state as “uncontrolled” creating a
greater risk for disease of the eyes, kidneys, and peripheral nerves which limits sensation and has
been linked to increased incidence of amputation of limbs (ADA, 2010). Cardiovascular disease
such as myocardial infarction and peripheral arterial disease has been linked to uncontrolled
HbA1C. The HbA1C was found to be higher among the group of individuals who use insulin as
part of their diabetes management. Insulin is recommended when glucose level is not controlled
with oral medications (ADA, 2010) and the findings were surprising as questions arise on the
rationale for this result.
A possibility for the insulin use group having a higher HbA1C may be that patients do
not follow prescribed therapy or may rely on insulin as the sole treatment for glucose control
without taking into consideration the importance of dietary intake and adherence to physical
activity. Other factors that may influence glucose control in individuals who use insulin may be
the concomitant intake of certain medications to treat existing co-morbid conditions. Such
medications may be corticosteroids used for inflammatory conditions and whose major adverse
effect is an increase in glucose levels.
It would be expected that those on insulin would have better glucose levels. However,
no information was available to the length of time with insulin, and additional factors that may
influence glucose control in this population to justify and gain knowledge regarding the findings
of this study.
The depression symptoms score as measured by BDI-II was a significant variable that
was linked to many of the variables included in this research. Surprisingly, one out of three
individuals included in this study reported scores greater than thirteen which is classified as mild
to severe depression symptoms score. This result represents a higher level than in previous
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studies. The identification of high presence of depression symptoms is significant in that the
there is an increased risk for heart disease as documented by Lichtman et al. (2008) and possible
increase in mortality (Zhang et al., 2005). Depression symptoms may also diminish the physical
health of individuals affected and may interfere in the person’s physical activity which is a
requirement for diabetes management and would ultimately affect glucose control. A positive
relationship identified between depression symptoms and perceived stress in this group of
diabetic individuals brings to light the need to prepare patients for possibility of its event.
The results derived from this study do not support the conceptual framework drafted for
this study where HbA1C was depicted as the variable that would have been connected and
ultimately affected by other variables in the study. The results reflect the depression symptoms
(BDI-II) score being related to most study variables. This creates significant clinical implications
in that the person needs to be evaluated not just by metabolic markers of disease state, such as
measurement of HbA1C, but also by psychological means such as application of stress or
depression screening questionnaires.
Study Limitations
Several limitations were identified in this research study. This was a convenience sample
of individuals with type 2 diabetes who were recruited from various private clinics. Therefore,
majority of the participants had some type of health insurance which increased greater
accessibility to health care services. This created a selective group that may not reflect the
Mexican-American population in the U.S. who is the largest group lacking health insurance in
the U.S.
The self-report of type 2 diabetes and health history components is a limitation of this
study. Self-report data collection method presents a threat to the validity of the measurements. It
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is also possible that when participants are asked personal questions may answer according to
what they believe is the socially acceptable answer.
The BDI-II is only a tool to detect depression symptoms and does not confirm a clinical
diagnosis of depression. To confirm depression a clinical exam and additional evaluation to rule
out underlying medical conditions would be necessary.
The physical health composite score (PCS) of the SF-36v2 is also a self-report. The
summed scores make up the scale which may lack strength in fully determining the actual
physical state of participants. The results are norm based to general U.S. population and may not
capture actual physical health state.
The instrument selected for measuring perceived stress (PSS) has not been widely used in
clinical settings and may not accurately measure the stress level in this population. Additionally,
the population in this research study had a lower formal education and was older as compared to
the population where this instrument has been used which was younger with greater formal
education years (Cohen, Kamarck, & Mermelstein, 1983).
Further limitation is identified in the acculturation level of this population.

The

acculturation scores were low with a large percentage of participants identifying Spanish as their
dominant language and reside in a predominantly Hispanic community. This created cultural
homogeneity in the sample and likely led to the limited variability in the statistical distribution of
this variable. The design of this study was a descriptive convenience sample and thus the
acculturation level findings are not generalizable to all Mexican-American individuals with type
2 diabetes. The acculturation level identified in this study is a limitation factor because of its low
acculturation scores.
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Cheriboga et al. (2007) warns of the possibility that depression symptoms scales may not
capture all components of clinical depression which may present in different manner according
to the culture or level of acculturation.
A more comprehensive medical history such as information on the length of time with
insulin use, insulin type, and the frequency or special considerations on the insulin
administration may have provided greater insight into factors that contributed to the difference in
the mean of HbA1C scores of those that used insulin and those who take oral medications for
diabetes management.
The completion of all the questionnaires was lengthy and it is possible that participants’
fatigue may have altered responses. Each participant took approximately ninety minutes to
complete the questionnaires and to have their serum blood test drawn.
Since this study was conducted in private family practice clinics, participants may have
felt pressured to participate to please their health care providers.

Since the majority of

participants preferred to complete questionnaires in Spanish and they were also approached in
their preferred language, it is possible that this influenced their decision to be in the study and
their answers to not be contradictory.
The statistical analyses conducted were guided by the research questions prepared to
answer the purpose for this study and this may be viewed as a limitation for this research study.
It is possible that greater depth and sophistication of statistical analyses of the variables included
in this study may yield different results that may significant information about MexicanAmerican individuals with type 2 diabetes.
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Implications for practice
The emergence of such high rate of depression symptoms along with its connection with
perceived stress score calls attention for the need to address the psychological state of individuals
with type 2 diabetes. Additionally, the large percentage of participants with uncontrolled type 2
diabetes is alarming. Health care practitioners need to seek out evidence based methods for
assisting individuals with type 2 diabetes to control glucose levels and lessen the risk of diabetes
related complications. Attending to traditional medical appointments may not suffice to assist in
the metabolic and psychological demands of type 2 diabetes.
The complexity of management of individuals with type 2 diabetes is evident in this
study as the person should not be treated solely on results of a metabolic exam but rather as an
entire person taking into consideration the personal characteristics and psychosocial profile of
the individual. Primary health care providers need to step away from the medication centered
approach and consider an interdisciplinary team approach for management of patients with type
2 diabetes. Perhaps consideration needs to be given to preparing diabetic individuals to the
psychological events that the chronic condition may cause and create interventions for
prevention of occurrence.
The high number of participants with HbA1C >7.0% alerts health care providers of the
need to probe further into the possible causes for this occurrence. Adherence to treatment has
been often addressed but exploration into its causation and intervention studies to improve
outcomes need to be considered. A proactive approach is necessary with open communication
with the patients and evaluation of social and environmental factors that may keep them from
achieving normal glucose control levels.
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Arrays of health care providers are presented with an opportunity for impacting health
care services by providing a holistic approach to patient care. The HbA1C is not the only factor
for evaluation during a medical visit but only a small measurable physiologic component of
potential risks for type 2 diabetes outcomes. The psychological evaluation needs to be
incorporated in the management to improve quality of life of type 2 diabetes patients.
Policy changes at the national and state level need to take place to improve access and
reimbursement for mental health services at the community level. The effectiveness of nurse case
managers as part of the team care approach for depression may improve access to psychological
services possibly at a lesser cost.

Primary care providers and consultants such as trained

Counselors and Nurses have been shown to be effective when working as a team in managing
individuals with depression (Gilbody et al., 2003). Utilization of trained counselors, nurses, and
social workers may assist in providing appropriate interventions to lessen stress and minimize
depression symptoms in type 2 diabetes. Instead of focusing in a pharmacological treatment
approach only; a comprehensive treatment is required to improve patient outcomes.
Because of the complexity of diabetes and the importance of self-management,
individuals affected need to be empowered through education and provision of community and
health care practitioner’s support to influence diabetes control and ultimately to prevent
complications. Health care practitioners need to be vigilant of possible factors that may hinder
the outcome of diabetes care and work with support health and community services to minimize
barriers to success of treatment.
The presence of depression in individuals with diabetes has been widely documented
(Black & Markides, 1999; Lustman et al., 2000). This study supported previous findings with
BDI-II scores showing moderate to severe depression symptom score (Lustman & Clouse, 2005).
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Physical health as measured by the SF-36v2 had a significant correlation with depression.
This is important because part of diabetes management is maintaining physical activity on a
regular basis to improve glucose control.

When a person is depressed the probability of

exercising diminishes does creating a potential effect in glucose control and ultimately
augmenting potential diabetes complications. Additionally as the U.S. population ages, a greater
incidence of type 2 diabetes is likely to occur and physical abilities related to aging may occur as
demonstrated by this study, where age was related to a decrease in physical function.
Future Research
A great opportunity for future research has surfaced with the results of this study. Studies
may be designed in the following areas: 1) assisting clinicians in recognizing the need to
evaluate for depression in patients with type 2 diabetes to initiate treatment, 2) interventions for
improving glucose control in Mexican- Americans and elderly, 3) interdisciplinary approach to
care of type 2 diabetes patients outside the medical model approach.
Health care practitioners need to consider ways to assist clinicians in detecting depression
symptoms in a timely manner with minimum requirement of time. The primary care doctors in
El Paso County are limited; the ratio of population per direct patient care physician is 905
patients to one primary care doctor (TDSHS, 2009). Time constraints are often verbalized by
clinicians as reason for not screening for depression symptoms on regular bases. The limited
number of primary care doctors creates a burden in actual time available for patient care.
The idea of a brief depression screening method has been explored and may provide an
opportunity for further evaluation in this population. The development of two questions,
extracted from most validated depression scales are being considered. The questions are related
to “depressed mood and low interest” (Mitchel, 2008, p.1936). Comparison studies on sensitivity
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and specificity for using the one and two questions as possible depression screening in cancer
patients are being evaluated (Mitchel & Coyne, 2007) have been exploring the possibility of
using ultra-short screening instruments to improve the probing of mood disorders since primary
care physicians may be overlooking the presence of this condition. The possibility of using these
two questions may help identify clinical depression. The use of the two questions for depression
symptoms finding in a medical practice was suggested by Whooley & Simon (2000), the two
questions included were "During the past month, have you often been bothered by (1) feeling
down, depressed, or hopeless, and (2) having little interest or pleasure in doing things?" (p.1943).
A positive answer to these questions would suggest further evaluation for clinical depression.
Application of intervention of diabetes treatment programs that have shown to be
successful in improving HbA1C in other areas may be considered. Programs such as Project
Dulce initiated in San Diego, CA where nurse diabetes educators manage the care of diabetic
individuals under the direction of a physician, and community health workers (promotoras) are
the patient’s peer educators. The population served in this program are individuals with type 2
diabetes of diverse ethnic backgrounds, of low income, who are uninsured or underinsured
(Philis-Tsimikas et al., 2004).

Development of an intervention study with components deemed

successful in Project Dulce is a feasible research opportunity for improving glucose control in
individuals affected by type 2 diabetes residing in the El Paso, Texas region.
Institutions of higher education in El Paso area are in a perfect setting for designing
intervention studies using an interdisciplinary team approach of care for individuals with
diabetes. The professional disciplines for possible inclusion in a holistic care approach to
individuals with diabetes are: Advanced Practice Nurses, Social Workers, Occupational and
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Physical Therapist, and Psychology Counselors. All of these professionals are available in the El
Paso, Texas region.
A great need exists for health care professionals to think and practice beyond the current
conventional medical treatment in order to positively impact the lives of those affected by type 2
diabetes independent of age and ethnic orientation.
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APENDIX A
PERMISSION FOR RECRUITMENT OF STUDY PARTICIPANTS
Participant identifier ____________

Interviewer_________________ Date___________

Date: ___________________

Dr. _Name_________
Address:
Dr._______________
I am conducting a research study to evaluate the association of diabetes with depression and its
effect on glucose control and physical function. This study has been approved by the UTEP’s
Institutional Review Board and is part of my Doctorate Dissertation. The information gained will
assist clinicians in understanding the association between diabetes and depression and design
interventions to lessen potential complications and improve patient outcomes.
I am asking for permission to approach your patients during their scheduled appointment, while
waiting in the waiting room, to see if they would be willing to participate in this study. The study
consists of completion of several questionnaires, including a depression scale, and a blood
sample will be drawn for a HbA1c. I will adhere to HIPAA regulations and maintain patient
confidentiality at all times. Your patient will bring you results of the A1C upon completion of
the study. I will inform you of any problems or concerns identified during the study. The time
for recruitment and the data collection will be approximately from October to December, 2009.
The proposal of this study is available for your review. Please feel free to contact my faculty
advisor Dr. R. Anders, Dean of School of Nursing at 915-747-8217. Thank you in advance.
Respectfully,

Guillermina Solis, RN, NP-C, Ph.D.(c)
College of Health Science
University Texas El Paso
1101 N. Campbell
El Paso, TX 79902
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APENDIX B
RECRUITMENT OF PARTICIPANTS
Please circle your answer
“I am doing a research study about people with Diabetes to learn more about this illness and to
help those affected”
Would you let me to talk to you about the study?

YES

NO

Por favor marque su respuesta
“Estoy haciendo un estudio con personas afectadas por Diabetes para saber más de esta
enfermedad y ayudar a los que la tienen”

Me permite platicar con usted de este estudio?

SI
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NO

APENDIX C
ENGLISH INFORMED CONSENT
University of Texas at El Paso (UTEP) Institutional Review Board
Informed Consent Form for Research Involving Human Subjects
Protocol Title: The Coexistence of Diabetes Mellitus Type 2 and Depression symptoms in
Mexican American Adults: Its effect on glucose control and physical function
Principal Investigator: Guillermina Solis, RN, NP-C, Ph.D.(c).
Main Advisor: Robert L. Anders, DrPH, APRN, CNNA, FAAN,
UTEP: College of Health Science
Introduction
You are being asked to take part voluntarily in the research project described below. Please take
your time making a decision and feel free to discuss it with your friends and family. Before
agreeing to take part in this research study, it is important that you read the consent form that
describes the study. Please ask the study researcher or the study staff to explain any words or
information that you do not clearly understand.
Why is this study being one?
You have been asked to take part in a research study of people with diabetes to learn more about
persons with diabetes, see whether they have depression symptoms, and how this may affect the
sugar level and the body.
Approximately, 140 people will be enrolling in this study to take place in El Paso, Texas. About
five Health Care clinics will participate with approximately 28 people from each.
You are being asked to be in the study because you are over the age of 18 and have identified
yourself as having Diabetes.
If you decide to enroll in this study, your total involvement will last two weeks.
What is involved in the study?
If you agree to take part in this study, the research team will:
• Explain the study
• Check to see if you are able to be in the study
• Have you complete five questionnaires about yourself given by the researcher or research
assistant
• Take a blood sample to check your average blood sugar, this will be done by a nurse or
laboratory person
• All this will be done in your Doctor’s office either before or after seeing your Doctor
• Take about 1.5 hours
• Only your blood results will be given to your Doctor about 10 days later.
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What are the risks and discomforts of the study?
There are no known risks associated with this research. However, you may become tired,
nervous or sad. You may have the following when your blood is taken: discomfort, pain, or
bruise. In rare event, infection from the needle stick may occur.
What will happen if I am injured in this study?
The University of Texas at El Paso and its affiliates do not offer to pay for or cover the cost of
medical treatment for research related illness or injury. No funds have been set aside to pay or
reimburse you in the event of such injury or illness. You will not give up any of your legal rights
by signing this consent form. You should report any such injury to Guillermina Solis @ 915630-3136 and to the UTEP Institutional Review Board (IRB) at (915-747-8841) or
irb.orsp@utep.edu.
Are there benefits to taking part in this study?
There will be no direct benefits to you for taking part in this study. This research may help health
professionals understand the psychological state of persons with diabetes and how this may
affect your sugar level and the body.
What other options are there?
You have the option not to take part in this study. There will be no penalties involved if you
choose not to take part in this study.
Who is paying for this study?
Internal Funding: Funding for this study is provided by a grant from UTEP Department of
Hispanic Health Disparities Research Center.
What are my costs?
There are no direct costs. You will be responsible for travel to and from the research site and any
other incidental expenses.
Will I be paid to participate in this study?
You will be given a $15.00 gift card for your participation at the end of this study
What if I want to withdraw, or am asked to withdraw from this study?
Taking part in this study is voluntary. You have the right to choose not to take part in this study.
If you do not take part in the study, there will be no penalty.
If you choose to take part, you have the right to stop at any time. However, we encourage you to
talk to a member of the research group so that they know why you are leaving the study. If there
are any new findings during the study that may affect whether you want to continue to take part,
you will be told about them.
The researcher may decide to stop your participation without your permission, if he or she thinks
that being in the study may cause you harm, if you are not able to complete the questionnaires, or
if not able to have your blood test done.
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Who do I call if I have questions or problems?
You may ask any questions you have now. If you have questions later, you may call: Guillermina
Solis@ 915-630-3136, gsolis2@utep.edu.
If you have questions or concerns about your participation as a research subject, please contact
the UTEP Institutional Review Board (IRB) at (915-747-8841) or irb.orsp@utep.edu.
What about confidentiality?
1. Your part in this study is confidential. None of the information will identify you by name. All
records will be kept in a locked cabinet in UTEP’s College of Health Science and only Ms.
Solis and her advisor will have access to the information.
2. The results of this research study may be presented at meetings or in publications; however,
your identity will not be disclosed in those presentations.
Mandatory reporting
If during the study, information is revealed about potentially dangerous future behavior towards
you or others, the law requires that this information be reported to the proper authorities.
Authorization Statement
I have read each page of this paper about the study (or it was read to me). I know that being in
this study is voluntary and I choose to be in this study. I know I can stop being in this study
without penalty. I will get a copy of this consent form now and can get information on results of
the study later if I wish.
Participant Name: _________________________________

Date: ____________

Participant Signature: ______________________________

Time: ____________

Consent form explained/witnessed by: ______________________________
Signature

Printed name: ______________________________

Date: ____________

Time: ____________
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APENDIX D
SPANISH INFORMED CONSENT
La Universidad de Tejas en El Paso (UTEP) Comité Examinador Institucional
Forma Informada del Consentimiento para la Investigación que Incluye Seres Humanos
Título del protocolo: La coexistencia de Diabetes Melitos Tipo 2 y los síntomas de depresión en
adultos Mexicanos-Americanos: Su efecto sobre el control de glucosa y la función física
Investigador principal: Guillermina Solis, RN, NP-C, Ph.D. (c)
Consejero principal: Robert L. Anders, DrPH, APRN, CNNA, FAAN
UTEP: Colegio de Ciencias de Salud
Introducción
Le están pidiendo participar voluntariamente en el proyecto de investigación descrito. Tómese su
tiempo para llegar a una decisión y siéntase libre de hablar con sus amigos y familia acerca de
esto. Antes de acordar participar en este estudio de investigación, es importante que usted lea la
forma del consentimiento que describe el estudio. Pida por favor que el investigador del estudio
o su personal le expliquen cualesquier palabra o información que no entienda claramente.
¿Por qué se está haciendo este estudio?
Le han pedido participar en un estudio de la investigación de gente con diabetes para aprender
más sobre personas con diabetes, ver si tienen síntomas de la depresión, y cómo éste puede
afectar el nivel del azúcar y el cuerpo. Aproximadamente 140 personas estarán en este estudio
en El Paso, Tejas. Cerca de cinco clínicas del cuidado médico participarán con aproximadamente
28 personas de cada una. Le están pidiendo estar en el estudio porque usted está sobre la edad de
18 años y ha identificado que tiene diabetes. Si usted decide participar en este estudio, su
participación total durará dos semanas.
¿Qué está incluido en el estudio?
Si usted está de acuerdo en participar en este estudio, el equipo de investigación hará lo
siguiente:
• Explicarle el estudio
• Revisar si puede usted estar en el estudio
• El investigador o su asistente se lo darán que complete cinco cuestionarios acerca de usted
• Le tomaran una muestra de la sangre para comprobar su promedio de azúcar, esto será hecha
por una enfermera o por la persona del laboratorio
• Todo esto se hará en la oficina de su doctor ya sea antes o después de ver a su doctor
• El proceso durara cerca de 1.5 horas
• Solamente sus resultados de la sangre serán dados a su doctor cerca de 10 días después
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¿Cuáles son los riesgos y los malestares del estudio?
No hay riesgos que nosotros sepamos asociados a esta investigación sin embargo, usted se puede
cansarse, se puede poner nervioso o triste. Cuando le tomen la sangre usted puede tener lo
siguiente: malestar, dolor, o moretón. En acontecimiento raro, puede tener infección debido a la
aguja cuando le saquen sangre.
¿Qué sucederá si me dañan en este estudio?
La Universidad de Tejas en El Paso y sus afiliados no ofrecen pagar ni cubrir el coste del
tratamiento médico para la enfermedad o lesión relacionada con la investigación. No se ha
preparado ningún fondo para pago o reembolso en caso de lesiones o enfermedades. Usted no
cederá cualquiera de sus derechos legales firmando esta forma de consentimiento. Usted debe
reportar cualquier lesión a Guillermina Solís al 915-630-3136 y al comité examinador
institucional de UTEP (IRB) al 915-747-8841 o irb.orsp@utep.edu.
¿Hay ventajas al participar en este estudio?
No habrá ventajas directas para participar en este estudio. Esta investigación puede ayudar a
profesionales de salud a entender el estado psicológico de las personas con diabetes y aprender
cómo ésta puede afectar el nivel del azúcar y al cuerpo.
¿Cuáles son mis opciones?
Usted tiene la opción a no participar en este estudio. No habrá ningún castigo o repercusiones si
usted decide no participar en este estudio.
¿Quién está pagando por este estudio?
Financiamiento interno: El financiamiento para este estudio es proporcionado por una concesión
del departamento de UTEP del Centro de Investigación de las Disparidades de Salud en los
Hispanos
¿Cuáles son mis costos?
No hay costos directos. Usted será responsable por llegar al sitio donde se conducirá la
investigación y por cualquier otro costo fuera del estudio
¿Me pagarán para participar en este estudio?
Al final del estudio se le obsequiara una tarjeta de $15.00 por su participación que puede ser
canjeada en ciertas tiendas locales
¿Qué si quiero retirarme, o me piden retirarme de este estudio?
Su participación en este estudio es voluntaria. Usted tiene derecho a elegir no participar en este
estudio. Si usted no participa en el estudio, no habrá ningún castigo. Si usted elige participar,
tiene derecho de retirarse del estudio en cualquier momento. Sin embargo, le animamos a que
hable con un miembro del grupo de investigación para saber porqué usted está dejando el
estudio. Si hay algunos nuevos detalles durante el estudio que pueden afectar su decisión de
participación, se le harán saber. El investigador puede pedirle que se retire del estudio sin su
permiso si él o ella piensan alguno de los siguientes: que el estar en el estudio puede hacerle
daño, si no puede terminar los cuestionarios, o si no es posible obtener su análisis de sangre
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¿A quién llamo si tengo preguntas o problemas?
Usted puede hacer cualquier pregunta que tenga ahora. Si usted tiene preguntas más adelante,
puede llamar a: Guillermina Solís al 915-630-3136, o correo electrónico gsolis2@utep.edu Si
usted tiene preguntas o preocupaciones acerca de ser participante de investigación, por favor
contacte al comité examinador institucional de UTEP (IRB) por teléfono al 915-747-8841, o
por correo electrónico al irb.orsp@utep.edu.
¿Cómo se mantendrá confidencialidad (secreto)?
1. Su participación en este estudio es confidencial. Ninguna de la información le identificará por
nombre. Todos los expedientes serán mantenidos en un gabinete seguro en la Universidad de
UTEP departamento de Ciencias de Salud. Únicamente La Sra. Solís y su consejero tendrán
acceso a la información.
2. Los resultados de este estudio de investigación puede que se presenten o se publiquen en
campos profesionales; sin embargo, su identidad no será divulgada en esas presentaciones.
Reporte obligatorio
Si durante el estudio, se revela información sobre comportamiento futuro potencialmente
peligroso hacia usted u otros, la ley requiere que esta información esté divulgada a las
autoridades apropiadas.
Declaración de autorización
He leído cada página de este documento sobre el estudio (o se me leyó). Sé que el participar en
este estudio es voluntario y elijo estar en este estudio. Sé que puedo dejar el estar en este estudio
sin castigo. Se me dará copia de esta forma de consentimiento y si deseo puedo conseguir la
información sobre los resultados del estudio más adelante.
Nombre del participante: _______________________
Firma del participante: ________________________

Fecha: ______________
Hora: ____________________

Forma del consentimiento explicada por/atestiguada por: __________________________
Firma
Nombre impreso de firma: ___________________________
Fecha: _____________

Hora: _________
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APENDIX E
HEALTH CARE PROVIDER NOTIFICATION
Participant identifier ____________

Interviewer_________________ Date___________

Date_____________
Dear Colleague___________
Your patient_________________ has participated in a research study on diabetes and
depression. As part of the study, a venous blood sample was taken to evaluate the HgA1C.
Please feel free to contact me at (915) 630-3136, if you have any questions.
Respectfully,
Guillermina Solis, RN, MS, NP-C, Ph.D. (c)
College of Health Science & School of Nursing
University Texas El Paso
1101 N. Campbell
El Paso, TX 79902
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APENDIX F
NOTIFICATION OF HBA1C RESULTS
Participant identifier ____________

Interviewer_________________ Date___________

Date_____________
Dear Colleague,
Your patient, _________________ participated in a research study on the Association of
Diabetes type 2 and Depression symptoms in Mexican American Adults on __________ (date
blood test done). As part of the study, the HbA1C was checked and the result was________%. I
have advised the participant to follow up with you for further evaluation.
Feel free to contact me if any questions or problems arise. My telephone number is 630-3136.
Respectfully,
Guillermina Solis, RN, NP-C, PhD(c)
College of Health Science & School of Nursing
University Texas at El Paso
1101 N. Campbell
El Paso, TX 79902
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APENDIX G
DEMOGRAPHIC AND HEALTH QUESTIONNAIRE
DIABETES AND DEPRESSIVE SYMPTOMS
AND ITS EFFECT ON GLUCOSE LEVEL
Participant identifier ____________

Interviewer_________________ Date___________

1.

What is your age? _________

2.

What is your sex? ( )Male ( )Female

3.

What is your country of birth? ____________

4.

If born in other country, how old were you? _________

5.

What is your father’s country of birth? ______________

6.

What is your mother’s country of birth? _____________

7.

What is your grandfather’s country of birth? ______________

8.

What is your grandmother’s country of birth? ______________

9.

What is your ethnicity? ( )Mexican-American

( )Mexican National

10. What is your main language at home? ( )English

( )Spanish

11. What is your marital status? ( )single ( )married ( )separated/divorced ( ) other______
12. What is your highest finished school grade? _________
13. Which is your employment status? ( )full time ( )part time ( )retired
( )unemployed

(

)housewife

( )disabled

14. If you work outside your home, what type of work do you do? _______________
15. What is your approximate family income? ___________ ( )year
16. Do you have Health Insurance? ( )Yes
( )Medicare

( )month

( )week

( )No If yes, what kind? ( )Private

( )Medicaid

17. Do you exercise, like walking or other? ( )Yes

( )No

18. If yes, how many times a week? _________ How much time? _________
Medical History:
How long have you had diabetes? _______
Do you take medicines for your diabetes? ( )Yes

( )No

Do you inject Insulin for your diabetes?

( )No

( )Yes
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What medicines do you take for diabetes?
______________________________________________________________________________
______________________________________________________________
What other medicines do you take? Include medicines without prescription:
______________________________________________________________________________
______________________________________________________________
Have you ever been told by a healthcare provider (such as a doctor or nurse) that you have
or have had any of the following health problems (check yes or no).
Arthritis
( ) Yes
( ) No
Depression

( ) Yes

( ) No

High Blood Pressure

( ) Yes

( ) No

High Cholesterol

( ) Yes

( ) No

Heart disease

( ) Yes

( ) No

Heart attack

( ) Yes

( ) No

Kidney disease

( ) Yes

( ) No

Poor circulation

( ) Yes

( ) No

Stroke

( ) Yes

( ) No

Other: ____________________________
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APENDIX H
EL EFECTO EN LA GLUCOSA DE PERSONAS CON DIABETES
Y SÍNTOMAS DE DEPRESIÓN
CUESTIONARIO DEMOGRÁFICO Y DE SALUD
Participant identifier ____________

Interviewer_________________ Date___________

1. ¿Que edad tiene? _______
2. ¿Cual es su sexo? ( )Masculino ( )Femenino
3. ¿En que país nació usted? _______________
4. Si nació fuera de Estados Unidos, ¿que edad tenía cuando llego? ________
5. ¿En que país nació su padre? ______________
6. ¿En que país nació su madre? ______________
7. ¿En qué país nació su abuelo? ______________
8. ¿En qué país nación su abuela?_____________
9. ¿Como se considera usted? ( )México-Americana ( ) Mexicana
10. ¿Que idioma habla en su casa? ( ) Ingles ( ) Español
11. ¿Cual es su estado civil? ( ) soltera ( ) casado(a) ( ) separado(a)/divorciado(a)
( ) otro_________
12. ¿Hasta que año estudio? ___________
13. ¿Trabaja usted? ( ) tiempo complete ( ) medio tiempo ( ) jubilado(a)
desempleado(a) ( ) ama de casa ( ) deshabilitado
14. Si trabaja fuera de su casa, ¿que tipo de trabajo tiene? ______________
15. ¿Cual es el ingreso familiar aproximado?__________( ) por ano ( ) por mes
( ) por semana
16. ¿Tiene usted aseguranza para servicios médicos? ( )Si ( )No
¿Cual tipo tiene? ( ) Privada ( ) Medicare ( ) Medicaid
17. Acostumbra hacer ejercicio, ¿como caminando u otro tipo? ( )Si ( ) No
18. Si hace ejercicio, ¿cuantas veces a la semana? ______Cuanto tiempo?_____
Historia Médica:
1. ¿Cuanto tiempo tiene con diabetes? ________años
2. ¿Toma medicinas para su diabetes?

( ) Si ( )No

3. ¿Se inyecta Insulina para su diabetes?

( ) Si ( )No
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( )

4. ¿Que medicinas toma para su diabetes?
___________________________________________________________________________
___________________________________________________________
5. Que otras medicinas toma? Por favor incluya las que compra sin receta?
___________________________________________________________________________
___________________________________________________________
6. ¿Alguna vez le ha dicho su proveedora de salud (doctor o enfermera) que tiene alguna de
estas enfermedades?
Artritis

( ) Si

( ) No

Depresión

( ) Si

( ) No

Alta Presión Arterial

( ) Si

( ) No

Colesterol Alto

( ) Si

( ) No

Enfermedad del corazón ( ) Si

( ) No

Infarto

( ) Si

( ) No

Embolio

( ) Si

( ) No

Enfermedad de riñones

( ) Si

( ) No

Mala Circulación

( ) Si

( ) No

Otros: ____________
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APENDIX I
PERCEIVED STRESS SCALE SCORING**
Instructions: The questions in this scale ask you about your feelings and thoughts during the last
month. In each case, please mark with a check how often you felt or thought a certain way.
______________________________________________________________________________
1. In the last month, how often have you been upset because of something that happened
unexpectedly?
___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often
2. In the last month, how often have you felt that you were unable to control the important
things in your life?
___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often
3. In the last month, how often have you felt nervous and "stressed"?
___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often
4 *. In the last month, how often have you felt confident about your ability to handle your
personal problems?
___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often
5*. In the last month, how often have you felt that things were going your way?
___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often
6*. In the last month, how often have you found that you could not cope with all the things
that you had to do?
___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often
7*. In the last month, how often have you been able to control irritations in your life?
___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often
8. In the last month, how often have you felt that you were on top of things?
___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often
9*. In the last month, how often have you been angered because of things that were outside
of your control?
___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often
10*. In the last month, how often have you felt difficulties were piling up so high that you
could not overcome them?
___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often
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11. In the last month, how often have you been angered because things that happened that
were outside of your control?
___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often
12. In the last month, how often have you found yourself thinking about things that you
have to accomplish?
___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often
13*. In the last month, how often have you been able to control the way you spend your
time?
___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often
14. In the last month, how often have you felt difficulties were piling up so high that you
could not overcome them?
___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often

Adapted from: Cohen, S. Kamarck, T., Mermelstein, R. (1983). A global measure of perceived
stress. Journal of Health and Social Behavior, 24, 385-396.
*Scored in these items are reversed; higher scores represent higher perceived stress.
TOTAL SCORE ________________
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APENDIX J
ADAPTATION OF THE PSS (14 ITEMS) FOR MEXICO [IN SPANISH]
Instrucciones: Marca la opción que mejor se adecue a tu situación actual, teniendo en cuenta el
último mes.
1. ¿Con que frecuencia has estado afectad/a por algo que ha ocurrido inesperadamente?
___0=Nunca ___1=Casi nunca ___2=De vez en cuando ___3=A menudo ___4=Muy a menudo
2. ¿Con que frecuencia te has sentido incapaz de control las cosas importantes de tu vida?
___0=Nunca ___1=Casi nunca ___2=De vez en cuando ___3=A menudo ___4=Muy a menudo
3. ¿Con que frecuencia te has sentido nervioso/a o estresado/a (lleno de tensión)?
___0=Nunca ___1=Casi nunca ___2=De vez en cuando ___3=A menudo ___4=Muy a menudo
4. ¿Con que frecuencia has manejado con éxito los pequeños problemas irritantes de la
vida?
___0=Nunca ___1=Casi nunca ___2=De vez en cuando ___3=A menudo ___4=Muy a menudo
5. ¿Con que frecuencia has sentido que has afrontado efectivamente los cambios
importantes que han estado ocurriendo en tu vida?
___0=Nunca ___1=Casi nunca ___2=De vez en cuando ___3=A menudo ___4=Muy a menudo
6. ¿Con que frecuencia has estado seguro/a sobre tu capacidad de manejar tus problemas
personales?
___0=Nunca ___1=Casi nunca ___2=De vez en cuando ___3=A menudo ___4=Muy a menudo
7. ¿Con que frecuencia has sentido que las cosas te van bien?
___0=Nunca ___1=Casi nunca ___2=De vez en cuando ___3=A menudo ___4=Muy a menudo
8. ¿Con que frecuencia has sentido que no podías afrontar todas las cosas que tenias que
hacer?
___0=Nunca ___1=Casi nunca ___2=De vez en cuando ___3=A menudo ___4=Muy a menudo
9. ¿Con que frecuencia has podido controlar las dificultades de tu vida?
___0=Nunca ___1=Casi nunca ___2=De vez en cuando ___3=A menudo ___4=Muy a menudo
10. ¿Con que frecuencia has sentido que tienes el control de todo?
___0=Nunca ___1=Casi nunca ___2=De vez en cuando ___3=A menudo ___4=Muy a menudo
11. ¿Con que frecuencia has estado enfadado/a porque las cosas que te han ocurrido
estaban fuera de tu control?
___0=Nunca ___1=Casi nunca ___2=De vez en cuando ___3=A menudo ___4=Muy a menudo
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12. ¿Con que frecuencia has pensado sobre las cosas que no has terminado (pendientes de
hacer)?
___0=Nunca ___1=Casi nunca ___2=De vez en cuando ___3=A menudo ___4=Muy a menudo
13. ¿Con que frecuencia has podido controlar la forma de pasar el tiempo (organizar)?
___0=Nunca ___1=Casi nunca ___2=De vez en cuando ___3=A menudo ___4=Muy a menudo
14. ¿Con que frecuencia has sentido que las dificultades se acumulan tanto que no puedes
superarlas?
___0=Nunca ___1=Casi nunca ___2=De vez en cuando ___3=A menudo ___4=Muy a menudo
CALIFICACION FINAL ________________

Adapted from: Gonzalez-Ramirez, M.T. & Landero-Hernandez, R. (2007). Factor structure of
the perceived stress scale (PSS) in a sample from Mexico. The Spanish Journal of Psychology,
10(001), 199-206
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APENDIX K
SHORT ACCULTURATION SCALE (ENGLISH)
Please mark the answer that describe your language preference
1. In general, what language(s) do you read and speak?
1
2
3
4
Spanish better
English better
Only Spanish
Both Equally
than English
than Spanish

2. What was the language(s) you used as a child?
1
2
3
Spanish better
Only Spanish
Both Equally
than English

4
English better
than Spanish

3. What language(s) do you usually speak at home?
1
2
3
Spanish better
Only Spanish
Both Equally
than English

4
English better
than Spanish

4. In which language(s) do you usually think?
1
2
3
Spanish better
Only Spanish
Both Equally
than English

4
English better
than Spanish

5. What language(s) do you usually speak with your friends?
1
2
3
4
Spanish better
English better
Only Spanish
Both Equally
than English
than Spanish

5
Only English

5
Only English

5
Only English

5
Only English

5
Only English

Marin G, Sabogal F, Van Oss Marin B, Otero-Sabogal R, Perez-Stable EJ. Development of a
short acculturation scale for Hispanics. Hisp J Behav Sci. 1987;9(2):183–205.

TOTAL SCORE: ___________

101

APENDIX L
SHORT ACCULTURATION SCALE (SPANISH)
Marque la respuesta que describa su preferencia de idioma(s)
1. Por lo general, que idioma(s) lee y habla usted?
1
2
3
Más Español que
Ambos
Solo Español
Ingles
por igual

4
Más Ingles
que Español

2. Cual fue el idioma(s) que hablo cuando era niño(a)
1
2
3
Más Español que
Ambos
Solo Español
Ingles
por igual

4
Más Ingles
que Español

3. Por lo general, en qué idioma(s) habla en su casa?
1
2
3
Más Español que
Ambos
Solo Español
Ingles
por igual

4
Más Ingles
que Español

4. Por lo general, en qué idioma(s) piensa?
1
2
3
Más Español que
Ambos
Solo Español
Ingles
por igual

4
Más Ingles
que Español

5. Por lo general, en qué idioma(s) habla con sus amigos(as)?
1
2
3
4
Más Español que
Ambos
Más Ingles
Solo Español
Ingles
por igual
que Español

5
Solo Ingles

5
Solo Ingles

5
Solo Ingles

5
Solo Ingles

5
Solo Ingles

Marin G, Sabogal F, Van Oss Marin B, Otero-Sabogal R, Perez-Stable EJ. Development of a
short acculturation scale for Hispanics. Hisp J Behav Sci. 1987;9(2):183–205.
CALIFICACION TOTAL:___________
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